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Previously, we found that mice overexpressing glutathione peroxidase 1 (GPX1) (OE) developed 
type 2 diabetes mellitus (T2DM)-like phenotypes and hyperinsulinemia and hyper-secretion of 
insulin after glucose stimulation were two primary effects of the cellular GPX1 overproduction. 
To understand how GPX1 overexpression led to these primary metabolic outcomes, we 
identified an islet protein, regenerating islet-derived 2 (Reg2), whose mRNA and protein level in 
islets were diminished by GPX1 overproduction. We hypothesized that the depleted REG2 in OE 
islets mediated the OE T2DM-like phenotypes. Firstly, we demonstrated that the biochemical 
regulation of REG2 by GPX1 was through modulating intracellular redox status both in vitro and 
in vivo. We then demonstrated a novel metabolic function of REG2 in rescuing several 
phenotypes in the OE mice including hyperinsulinemia, hyper-secretion of insulin after the 
glucose stimulation, hyperglycemia and hypertriglyceridemia. We further found that REG2 
suppressed insulin secretion in a glucose-dependent way, and that glucose metabolism served as 
the downstream signaling in vitro. In addition, we uncovered a potential functional domain in 
REG2, the C-type lectin domain, which might participate in the inhibition of glucose-stimulated 
insulin secretion (GSIS) by REG2.   
 
Recent human and animal studies have shown that selenium (Se) supplements lead to increased 
risk of developing T2DM. However, the underlying mechanisms are not well understood. Since 
GPX1 is the most abundant selenoprotein in the body, the OE mice might serve as a good animal 
model to study the effects of Se supplements. To determine if dietary Se deficiency could 
improve the T2DM-like phenotypes in OE mice, we fed WT and OE mice a Se-deficient diet or 
Se-supplemented diet for 4 months. We showed that dietary Se deficiency in the OE mice 
partially alleviated the T2DM-like phenotypes. Expression of genes and proteins related to 
insulin synthesis and secretion, as well as glycolysis, gluconeogensis and lipogenesis was down-
regulated by dietary Se deficiency.  
 
Taken together, these new insights into the regulation and function of Reg2 and Se have not only 
led to their identifications as important players in the diabetogenic risk of GPX1 overexpression 
and(or) Se supplements, but also raise the possibility to developing strategies to combat T2DM.  
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CHAPTER 1 
Overview 
 
1.1 Diabetes Mellitus 
Diabetes mellitus (DM) is a chronic endocrine disorder characterized by a persistent elevation of 
plasma glucose levels. According to the National Diabetes Fact Sheet from the Centers for 
Disease Control and Prevention (CDC) in 2011, nearly 26 million Americans have diabetes, and 
another 79 million U.S. adults have prediabetes. Diabetes is a public health burden as 
approximately $175 billion was annually spent on the treatment of the diseases.  
 
DM is classified into the following classes: type 1 diabetes mellitus (T1DM), type 2 diabetes 
mellitus (T2DM), gestational diabetes, monogenic forms of diabetes, and other rare forms of this 
disease (Mellitus, 2003). T1DM is characterized by insulin deficiency due to the loss of 
pancreatic  cells. It is an autoimmune disease in which the inflammatory reaction attacks and 
damages β cells, thus causing them to produce insufficient insulin (O'Rahilly, 2009). T2DM is 
characterized by insulin resistance, a condition in which body tissues do not respond to insulin 
(Stumvoll and Häring, 2001). It is often accompanied by insulin secretory defect, impaired 
glucose tolerance, hyperinsulinemia, and dyslipidemia (O'Rahilly, 2009; Stumvoll and Häring, 
2001). Gestational diabetes is characterized glucose intolerance during pregnancy, which is 
usually temporary and reversible (Mellitus, 2003). Other specific types of diabetes include 
maturity onset diabetes of the young (MODY) (Tattersall, 1998), congenital diabetes, cystic 
fibrosis, and steroid-related diabetes (Mellitus, 2003). 
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The most widely spread form of diabetes is T2DM (Rösen et al., 2001). In healthy individuals, 
pancreatic  cells secrete insulin that travels through the bloodstream to enhance glucose uptake 
in skeletal muscles, inhibit glucose production in the liver, and inhibit lypolysis in adipose tissue 
(Fig. 1.1). For individuals with T2DM, the cells in the insulin-sensitive peripheral tissues are 
resistant to insulin, resulting in glucose intolerance and an increased fasting glucose level as the 
glucose is unable to enter the body effectively (Fig. 1.1). During the early stages of T2DM, the 
amount of insulin released by pancreatic  cells increases fourfold to fivefold to adapt to insulin 
resistance and allow more glucose to enter the body (Kahn et al., 2006). This results in 
hyperinsulinemia that is characterized by abnormally elevated insulin circulating in the 
bloodstream. During the late stages of T2DM, persistent hyperinsulinemia eventually exhausts 
the  cells and causes a continued decline in  cell functionality, which results in insulin 
deficiency and further contributes to the pathogenesis of T2DM (Lei and Vatamaniuk, 2011).   
 
FIGURE 1.1 Type 2 diabetes mellitus. The diagram is based on http://infoaboutdiabetes.com/diabetes-
information/ 
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1.2 Hyperinsulinemia  
Hyperinsulinemia is seen in an increasing number of people (Hopper et al., 2012). 
Hyperinsulinemia is strongly associated with metabolic diseases, such as T2DM (Arslanian et 
al., 2002; Haffner and Miettinen, 1997; Haffner et al., 1992; Koopmans et al., 1997), non-
alcoholic fatty liver disease (Hurjui et al., 2012; Kawano and Cohen, 2013; Pirgon et al., 2013; 
Titov et al., 2012), obesity and hypertension (Modan et al., 1985). Primary hyperinsulinemia 
turned out to be the strongest predictor of dysglycemia development in a 24-year follow-up 
human study (Dankner et al., 2009). Transgenic hyperinsulinemic mice with 8 or 32 extra copies 
of the human insulin gene exhibited increased insulin resistance and hypertriglyceridemia, with 
significantly elevated plasma insulin and reduced insulin receptor binding (Marban et al., 1989; 
Roth et al., 2004). Alleviation of hyperinsulinemia can prevent or improve the development of 
metabolic diseases. Lowering insulin through pancreatic-specific knockout of the insulin 1 (Ins1) 
gene prevented high-fat diet-induced fat growth and obesity without causing insulin resistance in 
adult mice (Mehran et al., 2012). Blocking insulin secretion with diazoxide promoted weight loss 
in obese humans and rats with increased basal metabolic rate and fat oxidation, but not 
hyperglycemia (Alemzadeh et al., 2008; Alemzadeh et al., 1998).  
 
1.3 Insulin Synthesis and Secretion 
The islets of Langerhans constitute 1 to 2% of the mass of the pancreas and are endocrine cell 
conglomerates that contain hormone-producing cells such as insulin-secreting β cells. A majority 
of diabetes research focuses on the differentiation, function, and maintenance of pancreatic β cell 
mass (Sarsour et al., 2009). When insulin synthesis, secretion or β cell mass is affected, blood 
insulin level will be consequently altered and eventually result in the development of diabetes. 
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However, β cell function rather than β cell mass seems to be more crucial in the etiology of 
T2DM (Ashcroft and Rorsman, 2012). 50% pancreatectomy had only small effect on glucose 
tolerance, implying around 40% of β cells would be sufficient to maintain glycemia (Menge et 
al., 2008). Increased insulin secretion and improvement of diabetes by glucagon-like peptide-1 
(GLP-1) demonstrated the importance of β cell function in established T2DM (Ashcroft and 
Rorsman, 2012). β cell dysfunction is one of the events in the progression of T2DM (Sarsour et 
al., 2009). The reason why β cells are very susceptible to oxidative stress-induced damage is 
related to a very low intrinsic antioxidant capability (Grankvist et al., 1981).  
 
β cell function is reflected by its capacity to synthesize and secrete insulin. Maintaining normal 
insulin transcription is important for insulin production. Many transcription factors can bind to 
insulin gene promoter regions and regulate an insulin biosynthesis, such as pancreatic duodenal 
homeobox 1 (PDX1), neurogenic differentiation 1 (BETA2), and forkhead box A2 (FOXA2) 
(Melloul et al., 2002). PDX1 plays a pivotal role in pancreatic β cell function (Ahlgren et al., 
1998). BETA2 is crucial for islet β cell maturation, maintenance, and insulin biosynthesis 
(Anderson et al., 2009b). FOXA2 plays a central role in β cell development by binding to and 
transactivating Pdx1 (Gao et al., 2008).  
 
Besides insulin synthesis, insulin secretion is another key component in determining insulin 
levels in the bloodstream. Glucose is an important secretagogue of insulin secretion. When the 
level of blood glucose rises, glucose is rapidly transported into the cell by glucose transporter 2 
(GLUT2), which plays an important role in glucose signaling, insulin secretion, and biosynthesis 
(Guillam et al., 2000; Valera et al., 1994) (Fig. 1.2). The intracellular glucose is then 
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phosphorylated to glucose-6-phosphate (G6P) by glucokinase (GK) (German, 1993) (Fig. 1.2). 
Glucose is metabolized in glycolysis and then in a form of acetyl-CoA enters the TCA cycle 
(Fig. 1.2). The followed mitochondrial events result in increased respiration, oxidative 
phosphorylation and ATP synthesis, an increased ATP/ADP ratio, a closure of ATP-sensitive K
+
 
channels, an opening of the voltage-sensitive Ca
2+
 channels and an influx of  extracellular Ca
2+
, 
which results in insulin exocytosis (Fig. 1.2). During ATP synthesis in the mitochondria, a 
proton circuit across the mitochondrial inner membrane drives oxidative phosphorylation, 
coupling substrate oxidation and ADP phosphorylation (Lowell and Shulman, 2005). This 
process is positively associated with mitochondrial membrane potential (Mitchell, 1961). 
Uncoupling protein 2 (UCP2) is a mitochondrial anion carrier protein that increases proton leak 
across the mitochondria inner membrane. UCP2 dissipates energy stored in the form of the 
electrochemical potential gradient away from ATP synthase, decreases mitochondrial inner 
membrane potential and ATP/ADP ratio, and thus attenuates insulin release from pancreatic β 
cells (Dalgaard, 2012; Lowell and Shulman, 2005; Zhang et al., 2001).  
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FIGURE 1.2 Glucose-stimulated insulin secretion in a pancreatic  cell. Adopted from (De León and 
Stanley, 2007). 
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1.4 Reactive Oxygen Species (ROS) and Antioxidant Defenses 
ROS are toxic oxygen-containing molecules that are mainly produced by the mitochondrial 
electron-transport chain and oxygen-metabolizing enzymatic reactions (Sarsour et al., 2009). 
ROS consist of superoxide (·O2
-
), hydrogen peroxide (H2O2), and hydroxyl radical (
.
OH), and 
they are highly reactive in redox reactions. An excessive intracellular generation of ROS results 
in oxidative stress and significant impairment of cell structures, as ROS can induce damage of 
DNA, proteins, and lipids (Buechter, 1988). It is also perceived that ROS contribute to various 
human diseases including T2DM, metabolic syndrome, cancer, cardiovascular diseases, 
neurodegeneration, as well as aging (Chung et al., 2013; Kim et al., 2008; Sarsour et al., 2009).  
 
In T2DM, glucotoxicity from persistent hyperglycemia causes the overproduction of ROS 
(Poitout and Robertson, 2008). An elevated intracellular ROS can easily impair insulin synthesis 
or secretion in the β cells, resulting in the deterioration of glucose metabolism and eventually 
leading to diabetes (Evans et al., 2003). Chronic overconsumption of a high-sucrose or high-fat 
diet significantly alters ROS production and is highly associated with insulin resistance and 
diabetes in mice and humans (Anderson et al., 2009a; Bonnard et al., 2008; Mohanty et al., 
2002). H2O2 can inhibit insulin signaling by blocking insulin-induced tyrosine phosphorylation 
of insulin receptor  subunit in fibroblast cell lines and adipocytes (Hansen et al., 1999), and by 
decreasing insulin-induced RAC-alpha serine/threonine-protein kinase (AKT) phosphorylation in 
vascular smooth muscle cells (Gardner et al., 2003). Reduction of the intracellular ROS level 
significantly improves insulin sensitivity in mice fed a high-fat diet (Anderson et al., 2009a).  
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Paradoxically, it has become apparent that H2O2 can also function as signaling molecule to 
facilitate insulin signaling and improve metabolic syndrome. Czech et al. suggested that H2O2 
serves as an insulin mimetic in adipocytes (Czech et al., 1974), while May and colleagues further 
demonstrated its role in the transduction of insulin signals based on increased pyruvate 
dehydrogenase activity and lipid synthesis from glucose in adipocytes (May and de Haën, 1979). 
Mahadev et al. found that H2O2 enhanced insulin signaling through the PI3K/AKT pathway in 
adipocytes (Mahadev et al., 2001), and most recently, Loh and co-workers showed that ROS 
increased insulin sensitivity through ROS/PI3K/AKT signaling in muscle under both in vivo and 
in vitro conditions (Loh et al., 2009).  
 
In order to detoxify ROS and maintain cellular redox homeostasis, mammals have three cellular 
antioxidant defense systems: 1) antioxidant enzymes, such as GPX1, superoxide dismutase 
(SOD), and catalase (CAT); 2) non-enzymatic compounds like vitamin E, vitamin C, uric acid, 
and glutathione (GSH); 3) sequestration and repairing systems (Lei and Vatamaniuk, 2011). 
Pancreatic β cells are considered to be low in free radical quenching (antioxidant) enzymes and 
thus more susceptible to oxidative stress (Grankvist et al., 1981). The health benefits of 
antioxidants are well known, and more than 30% of the U.S. population takes antioxidants from 
daily supplements of vitamins and minerals (Loya et al., 2009; Millen et al., 2004). However, a 
number of recent animal studies and clinical trials have failed to prove that antioxidants played a 
beneficial role in preventing or treating T2DM (Chen et al., 2005; Czernichow et al., 2006; Li et 
al., 2006; Liu et al., 2006; McClung et al., 2004; Song et al., 2009). Global overexpression of an 
antioxidant enzyme, GPX1, led to the development of insulin resistance, hyperglycemia, 
hyperinsulinemia and obesity in mice (McClung et al., 2004). 
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1.5 Se, Selenoproteins, and GPX1 
Se is an essential trace element that serves as an important antioxidant in human and animal 
nutrition. The recommended dietary allowance (RDA) for Se is 55 g/day for adults. Se 
deficiency is associated with Keshan disease (Chen et al., 1980), Kashin-Beck disease (Xu et al., 
1991), and Behcet’s disease (Esalatmanesh et al., 2011). The role of Se in preventing cancer has 
been of great interest, as Se supplements have reduced the incidence of several types of 
carcinoma (Clark et al., 1996). In addition, Se is considered to be anti-diabetic (Faure, 2003; 
Mueller and Pallauf, 2006) due to its insulin-mimetic effect (Ezaki, 1990). However, a number 
of recent human studies have shown a hyperglycemic, hyperlipidemic, and pro-diabetic effect 
from Se supplements (Bleys et al., 2007; Bleys et al., 2008; Laclaustra et al., 2010; Stranges et 
al., 2010a; Stranges et al., 2007; Stranges et al., 2010b). In addition, the Se and Vitamin E 
Cancer Prevention Trial (SELECT) study found a correlation between Se supplements and the 
increased development of T2DM in men (Lippman et al., 2009). In line with these studies, we 
found that a prolonged feeding of high dietary Se (3 mg/kg) induced mild gestational diabetes in 
the first-parity pregnant rats and insulin resistance in their offspring (Zeng et al., 2012). 
Meanwhile, Labunskyy and collegues have also shown similar effects of Se on body glucose and 
lipid metabolism (Labunskyy et al., 2011).  
 
The functional moiety of Se in selenoproteins is selenocysteine (Sec), as the antioxidant 
properties of Se appear through the co-translational insertion of Sec in selenoproteins. This 
insertion requires a UGA termination codon (Chambers et al., 1986) and Sec insertion sequence 
(SECIS) elements (Berry et al., 1991) to complete translation. Sec is identical to cysteine except 
that it contains a Se atom instead of sulfur. The Se atom is typically ionized at physiological pH 
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(Jacob et al., 2003) and is critical for proper selenoprotein functionality (Gasdaska et al., 1999; 
Lee et al., 2000). The SECIS element is a stem-loop structure that resides downstream of the 
UGA codon in the 3’-untranslated regions of eukaryotic selenoprotein transcripts. The 
recognition and insertion of the UGA stop codon as a Sec codon requires the presence of SECIS, 
tRNA
Sec
, a Sec-specific elongation factor, and SECIS-binding proteins (Caban and Copeland, 
2006).   
 
To date, twenty-five selenoproteins are identified in humans. Their biochemical activities are  
involved in oxidoreduction, selenocysteine synthesis and Se transport (Moghadaszadeh and 
Beggs, 2006). Six forms of glutathione peroxidase (GPX)  have been identified so far, and four 
of them (GPX1, GPX2, GPX3 and GPX4) contain Se in the form of selenocysteine residue 
(Forstrom et al., 1978). Among the four GPXs containing selenocysteine, GPX1 is the most 
abundant form, which incorporates four atoms of Se per 84 kDa (Rotruck et al., 1973). GPX1 is 
considered to be the main storage form of body Se (Burk, 1991), which may be the reason why 
its mRNA expression and enzyme activity are more susceptible to dietary Se deficiency than 
other selenoproteins (Bermano et al., 1995). 
 
GPX1 is the first identified selenoprotein and is an antioxidant enzyme that catalyzes the 
reduction of H2O2 to water (H2O) using GSH as a reducing agent in erythrocytes (Mills, 1957) 
and other types of cells. Using the GPX1 knockout mouse model, our lab had previously 
demonstrated the protection role of GPX1 on paraquat-induced depletion of NADPH and NADH 
(Cheng et al., 1999a), diquat-induced lethal oxidative stress (Fu et al., 1999), as well as ROS-
mediated oxidative injuries (Fu et al., 2001). Furthermore, this role of GPX1 cannot be replaced 
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by a high level of dietary vitamin E supplement (Cheng et al., 1999b). These studies are in line 
with other research that has demonstrated the protective role of GPX1 in myocardial and brain 
ischemia reperfusion injury (Crack et al., 2001; Yoshida et al., 1997).   
 
1.6 Regenerating Islet-Derived Protein (Reg) Family Proteins 
The Reg family proteins have been studied for over 25 years (Terazono et al., 1988). There are 
seven identified Reg proteins in mice, five in humans, and five in rats (Parikh et al., 2012). The 
mouse Reg proteins are classified into four types: (1) mReg1; (2) mReg2; (3) mReg3, mReg3, 
mReg3, and mReg3; and (4) mReg4. The human and rat Reg families are grouped into three 
types: (1) hReg1, hReg1, and rReg1; (2) hReg3, rReg3, hReg3, and rReg3; and (3) 
hReg4, rReg4 (Parikh et al., 2012) (TABLE A.).  
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TABLE A. Classification of Reg members in (A) mouse, (B) human and (C) rat. Adopted from 
(Parikh et al., 2012). 
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All Reg family proteins contain a highly conserved C-type lectin domain (CTLD), which 
consists of six cysteine residues (Fig. 1.3). The six cysteine residues are located in identical 
positions, suggesting a similar organization of the disulphide bridges in the REG protein 
structures. CTLD enables REG proteins to protect the gut from intestinal microbiota (Lehotzky 
et al., 2010; Mukherjee et al., 2009; Mukherjee et al., 2013). The antibacterial effect results from 
their binding to peptidoglycan carbohydrates to recognize bacterial targets (Cash et al., 2006; 
Christa et al., 1994; Ho et al., 2010; Lehotzky et al., 2010), oligomerizing on the bacterial 
membrane and forming a membrane-penetrating pore (Mukherjee et al., 2013).  Besides CTLD, 
there are some other important residues or motifs conserved in some of the REG proteins. The 
residues with dark green background (Fig. 1.3) are the prosegment of rREG1, mREG3, and 
hREG3 that are involved in bactericidal effect and fibril formation (Gurr W, 2012). The EPN 
motif (lime green background) and the loop1 and loop2 (grey background) in hREG3 (Fig. 1.3) 
were found to be involved in carbohydrate binding (Gurr W, 2012). Since the EPN motif is 
conserved in mREG3, rREG3, mREG3, rREG3, and hREG3, as shown in Figure 1.3, it is 
logical to predict that these REG3 proteins might be also engaged in carbohydrate binding via 
specific amino acid residues. The N-terminal fragment (NtfrII, light blue background) and C-
terminal fragment (CtfrII, lime green background) of mREG2 exhibited opposite roles in the 
development of T1DM in NOD mice (Gurr et al., 2007) (Fig. 1.3). Vaccination of NtfrII in NOD 
mice accelerated T1DM with activation of autoaggressive T-cells, while vaccination of CtfrII in 
NOD mice delayed T1DM (Gurr et al., 2007).  
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FIGURE 1.3 Primary sequence alignments for REG proteins. Adopted from (Gurr W., 2012). 
 
The factors that regulate Reg expression include cytokines, hormones, and nutrients. Tumor 
necrosis factor-alpha (TNF),  interferon-gamma (IFN) or a combination of interleukin-6 (IL-6) 
with dexamethasone treatment significantly induced Reg1 mRNA expression in pancreatic acinar 
cells (Dusetti et al., 1996) and RINm5F  cells (Akiyama et al., 2001). Glucocorticoids directly 
stimulated the transcription of mouse Reg2 and Reg3 genes in both pancreatic acinar and  cells 
(Luo et al., 2013). Interleukin-22 (IL-22) and interleukin-10 (IL-10) activated the mouse Reg3 
mRNA transcription in acinar and AR42J cells, respectively. IL-6 activated rat Reg3 in PC12 
cells (Broekaert et al., 2002), whose promoter region has two IL-6 response elements (T
-
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266
TCCCAG
-260
 and T
-249
TCCCAG
-243
) (Dusetti et al., 1995). The transcription factors activator 
protein-1 (AP-1), NeuroD1/Beta2, and signal transducer and activator of transcription (STAT) 
up-regulated the promoter activity of mouse Reg3, while PDX-1 suppressed the activity in HIT-
T15 cells (Taylor-Fishwick et al., 2006).  
 
The Reg family is a group of secretory proteins and was proposed to interact with its own 
putative receptors at the plasma membrane of the cells. Some research groups showed that Reg 
proteins were detectable in blood (Bacon et al., 2012; Carrère et al., 1999; Keel et al., 2009; 
Orelle et al., 1992; Zenilman et al., 2000) and might act as a hormone-like secretory substance 
with an endocrine or paracrine function (Carrère et al., 1999). Higher levels of circulating 
hReg1 were found in hepatocyte nuclear factor 1 alpha (HNF1A-MODY) patients and T1DM 
patients than in healthy individuals, suggesting hReg1 may be a clinical indicator of  cell 
apoptosis (Bacon et al., 2012). hReg1 was significantly increased in the serum of patients with 
sepsis and infections, indicating that it could be a marker for posttraumatic complications (Keel 
et al., 2009). Serum Reg1 and Reg3 levels are sensitive markers for pancreatic injury, as a large 
amount of the proteins was detected in the serum of pancreatitis patients and animal models 
(Orelle et al., 1992; Zenilman et al., 2000). Therefore, Reg proteins may serve as useful clinical 
biomarkers for the evaluation of exocrine pancreatic function,  cell apoptosis, acute 
pancreatitis, and other posttraumatic complications. 
 
Reg proteins act as growth factors, acute phase reactants, lectins, and antimicrobial factors in 
islet  cells, pancreatic acinar cells, hepatocytes, neurons, enterocytes, and epithelial cells (Baeza 
et al., 1996; Cavard et al., 2006; Harris et al., 2012; Lai et al., 2012; Orelle et al., 1992). They are 
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involved in diseases such as diabetes (Gurr et al., 2007; Planas et al., 2006; Watanabe et al., 
1994; Xiong et al., 2011), gastrointestinal cancer (Bishnupuri et al., 2006), hepatocellular 
carcinoma (Cavard et al., 2006; Christa et al., 1994), melanoma (Valery et al., 2001), 
neurodegeneration diseases (Acquatella-Tran Van Ba et al., 2012), and wound repair and 
psoriasis (Lai et al., 2012). In diabetes, Reg proteins exhibit different functions in various 
conditions. Reg1 and islet neogenesis-associated protein (INGAP-related peptide, Reg3) have 
been implicated in promoting of insulin synthesis and secretion via  cell 
proliferation/regeneration and neogenesis (Kakita et al., 2002; Rafaeloff et al., 1997; Takasawa 
et al., 2006; Terazono et al., 1988; Wise et al., 2004). Two-months intraperitoneal injection of 
REG1 protein (1mg/kg per day) in rats with surgical diabetes ameliorated their diabetes 
symptoms: decreased blood glucose with markedly decreased glucosurea, increased beta-cell 
mass, and elevated insulin secretion (Watanabe et al., 1994). However, contrary to the above 
discovery, mice overexpressing Reg1 in pancreatic  cell exhibited increased β cell apoptosis 
and decreased insulin secretion (Kondo et al., 2000). Mice overexpressing Reg3β specifically in 
pancreatic islets showed reduced insulin content in the pancreas, decreased islet GLUT2 protein, 
impaired glucose tolerance, and a decreased trend of GSIS both in vivo and in vitro (Xiong et al., 
2011).  
 
1.7 Regenerating Islet-Derived 2 (Reg2) 
Reg2 was first discovered by Unno and co-workers in 1993 (Unno et al., 1993). It is a small 
protein with 173 amino acids (Fig. 1.4A). Mouse REG1 and REG2 share 76% amino acid 
homology (Unno et al., 1993), which helps to predict the three-dimensional protein structure of 
REG2 (Fig. 1.4B) based on the crystal structure for REG1 (Bertrand et al., 1996). However, they 
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possess several unique characteristics, and their regulations and functions vary (Baeza et al., 
1997; Deane et al., 2002; Lasserre et al., 1994; Milner and Hales, 1967; Perfetti et al., 1996; 
Planas et al., 2006; Unno et al., 1993; Zhong et al., 2007).  
 
Several studies have indirectly implied that REG2 was a stress-induced protein. Both Reg2 
messenger RNA and protein level were significantly increased by chemical-induced pancreatitis 
in mice (Huszarik et al., 2010; Lu et al., 2006; Zhong et al., 2007). Reg2 gene promoter activities 
in pancreatic acinar and islet cells were also significantly increased by glucocorticoids and IL-6 
treatment (Luo et al., 2013), which suggested that the Reg2 gene promoter was highly responsive 
to pancreatic inflammation and oxidative stress. AP-1 is an oxidative stress sensor transcription 
factor. The AP-1 binding sites in 1500 bp Reg2 promoter region (Fig. 1.4C) may provide a link 
between an oxidative stress and REG2 transcriptional regulation.  
 
The biological function of Reg2 in T2DM remains elusive. Reg2 was found to be expressed in 
pancreatic β cells (Gurr et al., 2007; Huszarik et al., 2010; Planas et al., 2006), acinar cells 
(Wang et al., 2011c; Zhong et al., 2007), or both (Lu et al., 2006). However, Reg2 seems to be 
more functional in β cells than in acinar cells. Overexpression of the Reg2 gene in mouse 
insulinoma cells protected the cells from STZ-induced mitochondrial apoptosis (Liu et al., 2010), 
while pancreatic acinar-specific overexpression of Reg2 in mice did not change glucose 
homeostasis nor show any protection against diabetes and pancreatitis (Li et al., 2010). REG2  
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FIGURE 1.4 Bioinformatics analysis of mouse Reg2. (A) Amino acid sequence. (B) Predicted three 
dimensional protein structure. (C) 1500 bp Reg2 promoter region with putative AP-1 binding sites.  
 
 
 
 
 
A. B. 
C. 
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overexpression in NOD diabetic islets correlated with the acceleration of diabetes (Planas et al., 
2006). Also, REG2 was reported to be a novel β cell-derived autoantigen in NOD mice that may 
be involved in islet self-destruction (Gurr et al., 2007).  
 
To identify the underlying molecular mechanism for the hyperinsulinemia in OE mice, we 
screened 25 insulin-related gene changes in WT and OE islets. We found that, when compared to 
WT islets, OE islets exhibited higher insulin-related gene expression, such as Ins1, Pdx1 and 
Foxa2, and lower Ucp2 expression (Fig. 1.5A). More strikingly, we observed that Reg2 mRNA 
expression was diminished in OE islets when compared with WT islets across all ages (Fig. 
1.5A, B). However, no differences in the expression of Reg1 were found in the islets of the two 
genotypes (Fig. 1.5A).  
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FIGURE 1.5 Different insulin-related gene expressions in WT and OE islets. (A) mRNA level of 
Ins1, Pdx1, Foxa2, Ucp2, Reg1 and Reg2 in WT and OE islets. (B) Reg2 mRNA level in WT and OE 
islets isolated from 6-7 weeks, 6 months and 12 months old mice. Data presented as mean ± SE (n = 5 to 
6 for panels A and B). Means for a given gene without sharing a common letter differ (* P  0.05 vs. 
WT). 
A. 
B. 
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1.8 Objectives 
Our lab previously showed T2DM-like phenotypes in mice overexpressing GPX1 (McClung et 
al., 2004). And we demonstrated the hyperinsulinemia phenotype as the primary outcome of 
GPX1 overproduction (Wang et al., 2008). Thus, the overall objective of this dissertation is to 
understand how GPX1 overexpression led to the T2DM-like phenotypes. Because we identified 
an islet gene, Reg2, whose mRNA level in islets was diminished by GPX1 overproduction (Fig. 
1.5A, B), we hypothesized that the depleted REG2 in OE islets mediated the OE T2DM-like 
phenotypes. In Chapter 2, the objectives were to determine whether or not ROS regulates REG2 
protein expression and whether or not exogenous REG2 administration alleviates T2DM-like 
phenotypes in OE mice. In Chapter 3, the study was designed to investigate the molecular 
mechanisms of REG2 protein in regulating insulin secretion in vitro.  
 
Although Se exhibited anti-diabetic effects (Faure, 2003; Mueller and Pallauf, 2006), an 
accumulating number of recent human studies have shown that Se supplements had 
hyperglycemic, hyperlipidemic, and pro-diabetic effects (Bleys et al., 2007; Bleys et al., 2008; 
Laclaustra et al., 2010; Stranges et al., 2010a; Stranges et al., 2007; Stranges et al., 2010b). 
Because GPX1 is the most abundant selenoprotein in the body, OE mice serve as an ideal animal 
model to study how Se supplements potentiate T2DM in humans. In Chapter 4, the research was 
focused on whether or not dietary Se deficiency precluded GPX1 overproduction and rescued 
T2DM-like phenotypes in OE mice. 
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CHAPTER 2 
Metabolic Function of REG2 in GPX1 Overexpressing Mice 
2.1 Abstract 
Previously, we found that cellular GPX1 overexpressing (OE) mice developed hyperglycemia, 
hyperinsulinemia, insulin resistance and obesity, and that hyperinsulinemia and hyper-secretion 
of insulin after glucose stimulation were primary outcomes of GPX1 overexpression in OE mice. 
More strikingly, we found that OE islets had depleted Reg2 mRNA compared with WT islets. In 
order to determine how REG2 is downregulated by GPX1 overexpression and whether REG2 is 
the mediator of the T2DM-like phenotypes of OE mice, we examined the REG2 protein change 
after treating islets with various chemicals that could alter intracellular ROS level, and we 
examined the change of metabolic parameters after injecting 1-year-old OE mice with 
recombinant REG2 protein. We found that the expression of islets REG2 protein level 
dramatically decreased in OE as compared to the WT mice. We showed that ebselen, sodium 
selenite (Na2SeO3), or N-acetyl cysteine (NAC) treatment significantly downregulated REG2 
level, while H2O2 treatment up-regulated REG2 level in WT and OE islets. Diquat (DQ) or 
streptozotocin (STZ) injection in mice also increased REG2 protein level in both WT and OE 
pancreas. Fifteen-minute pre-injection of recombinant REG2 protein significantly decreased 
glucose stimulated insulin secretion (GSIS) and glucose tolerance in OE mice, and two-week 
long daily administration of exogenous REG2 protein alleviated hyperinsulinemia, 
hyperglycemia and hypertriglyceridemia in 1-year-old OE mice. Thus, GPX1 down-regulated 
REG2 level by modulating intracellular ROS level in islets, while exogenous REG2 
administration partially rescued T2DM-like phenotypes in OE mice.  
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2.2 Introduction 
GPX1 is a major intracellular antioxidant enzyme functioning as a scavenger of intracellular 
ROS by using GSH as a substrate (de Haan et al., 1998; Esposito et al., 2000; Mirochnitchenko 
et al., 1995; Taylor et al., 1993). Although some studies demonstrated the protective role of 
GPX1 in oxidative injuries (Cheng et al., 1999a; Crack et al., 2001; Fu et al., 2001), 
accumulating evidence suggests that dysregulation of GPX1 is involved in the development of 
metabolic syndrome. An up-regulation of GPX1 activity has been correlated with higher insulin 
levels and insulin resistance in healthy pregnant women (Chen et al., 2003). OE mice developed 
hyperinsulinemia, elevated GSIS, hyperglycemia, insulin resistance, and obesity at the age of six 
months (McClung et al., 2004), while chronic hyperinsulinemia was defined as a primary 
outcome of GPX1 overproduction in OE islets (Wang et al., 2008). Compared with wild type 
(WT), OE islets showed a 20-fold enhancement of GPX1 activity, decreased intracellular ROS 
production, and increased mitochondrial membrane potential (Wang et al., 2008).  
 
Islet Reg2 mRNA was diminished in the OE mice aged 6-7 weeks, 6 months, and 12 months 
(Fig. 1.5B). Pancreatic REG2 protein level was found to be inversely related to GPX1 expression 
in mice fed a high-fat diet (Qiu et al., 2005). Oxidative stress might mediate the inverse 
correlation between Reg2 and GPX1 as several studies have implied that REG2 is a stress-
induced protein. Reg2 gene promoter activity in both pancreatic acinar and islet cells was 
significantly increased by glucocorticoids treatment (Luo et al., 2013), which helps explain the 
up-regulated mRNA and protein expression of Reg2 in mice with chemical-induced pancreatitis 
(Huszarik et al., 2010; Lu et al., 2006; Zhong et al., 2007).  
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Reg2 was shown to be inversely correlated with low insulin levels. NOD diabetic mice had 
increased pancreatic Reg2 expression while no detectable pancreatic insulin mRNA (Sanchez et 
al., 2000). Overexpression of Reg2 in islets correlated with acceleration of diabetes in the NOD 
mouse model (Planas et al., 2006; Sanchez et al., 2000). Human Reg1 (hReg1), which shares 
63% homology with mouse Reg2 (Thompson et al., 2002), was found to have a higher 
expression in adult than in fetus pancreas, while insulin gene expression showed the opposite 
change to hReg1 (Sanchez et al., 2001).  
 
Considering the diminished islet Reg2 mRNA in OE mice, and the correlation among Reg2, 
oxidative stress and diabetes, we raised the questions of how REG2 expression was down-
regulated by GPX1 overexpression and whether or not the depleted REG2 was the mediator of 
the T2DM-like phenotypes of OE mice. To address the questions, we examined the REG2 
protein change after treating islets with various chemicals that can alter intracellular ROS level, 
and we determined metabolic responses of the 1-year-old OE mice after injections of the 
recombinant REG2 protein. 
 
2.3 Materials and Methods 
Mouse and Diet 
All mouse experiments were approved by the Institutional Animal Care and Use Committee at 
Cornell University. Mice were reared in plastic cages in an animal room with a constant 
temperature (22C) and a 12-h light:dark cycle, and were given a Torula yeast and sucrose-based 
diet (TABLE B.) (Cheng et al., 1997) with 0.3 mg Se/kg (as sodium selenite) and distilled water 
added. The OE mice were derived from a B6C3 (C57B1 x C3H) hybrid line (Cheng et al., 1997). 
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Mice were feed-deprived for 8 hours overnight before measurements, tests, and tissue sample 
collection.  
 
Quantitative Real Time PCR Analysis 
Islets were isolated from WT and OE mice using collagenase and were handpicked under a 
dissection microscope, as outlined in the standard protocol with minor modifications (Wang et 
al., 2008). Total RNA was extracted from the primary islets by using the Trizol reagent 
(Invitrogen, Carisbad, CA). The concentration and integrity of diluted samples were determined 
using a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA), and 1 g (10 l) of RNA 
was reverse transcribed into cDNA using 1 l each of dNTP and Oligo(dT) in a 5 minute 65C 
reaction using a thermocycler, followed by 4 l 5x First Strand Buffer, 2 l 0.1 M DTT, 1 l 
RNase OUT, and 1 l Superscript III at 50C for 50 min and 70C for 15 minutes. 1 l of cDNA 
was loaded into each well of 384 well qPCR plates and was reacted with 3 l ddH2O, 5 l 
SybrGreen PCR Master Mix and 0.5 l forward and 0.5 l reverse primer for 40 cycles with a 
Tm of 60C. -actin was used as a reference gene and the 2^-ddCt method was used for all 
analysis of the results (Schmittgen and Livak, 2008). 
 
Immunoblotting 
Islet, pancreas, or other tissues were placed in a protein lysis buffer containing 25 mM Tris-HCl 
(pH 7.4), 10 mM Na3VO4, 100 mM NaF, 50 mM Na4P2O7, 10 mM EGTA, 10 mM EDTA, 1% 
Triton X-100, 5 g/ml aprotinin, 10 nM okadaic acid, and 2 mM phenylmethylsulfonyl fluoride 
(PMSF). After homogenization on ice, cell lysate was centrifuged at 4C, 14000RPM, for 15 
minutes. The supernatant was collected and assayed for protein quantification via BCA assay 
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(Thermo Scientific, Rockford, IL). The rest supernatant was used for Immunoblotting analysis. 
For Immunoblotting, islet lysate supernatant was heated at 100C heat block for 5 minutes and 
resolved by an SDS-PAGE gel, transferred to a nitrocellulose membrane, and blocked in a 3% 
milk/TBST solution for 1 hour. The membrane was incubated with primary antibodies (diluted in 
TBST) at 4C, overnight, washed in TBST (3 X 15 minutes), and incubated with secondary 
antibodies (also diluted in TBST) for 1 hour at room temperature. Following 3X washes in 
TBST, the signals on the membrane were detected using a Pierce ECL Immunoblottingting 
System (Thermo Scientific, Rockford, IL). 
 
Immunohistochemistry 
The whole pancreatic tissue was removed from WT  mice, fixed in 4% paraformaldehyde (PFA) 
at 4C overnight, washed 3 times in PBS, and transferred into 70% ethanol and placed into a 
cassette for embedding (Histology Lab, Schurman Hall, Cornell University). The embedded 
samples were sectioned at 5 m, and the slides were rehydrated through xylenes and decreasing 
grades of alcohol. The slides were then washed with PBS/Triton X-100, blocked with 10% 
BSA/PBS for 1.5 hours, incubated with REG2 primary antibody (diluted 1:500 in 3% milk/PBS) 
overnight at 4C. The next day, the slides were washed with PBS/Triton X-100, and secondary 
antibody was applied (diluted 1:2000 in 1% BSA/PBS) at room temperature for 1 hour. After 
washing with PBS/Triton X-100, the slides were dehydrated through increasing grades of alcohol 
and xylenes. Positive staining was observed via fluorescence microscopy. Carol A. Roneker 
performed this procedure.   
 
Immunoprecipitation 
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A whole cell lysate protein was incubated with protein G beads (Santa Cruz, Dallas, TX) 
with/without REG2 antibody (a gift from Dr. Omary) (Zhong et al., 2007) at 4C overnight. 
Protein G beads with REG2 antibody served as the negative control. Samples were washed five 
times with washing buffer, and proteins were eluted using an SDS-PAGE loading buffer at 
100C for 5 minutes. After centrifugation, supernatant was loaded into SDS-PAGE gels for 
immunoblotting detection.   
 
Islet Culture 
After being isolated from the pancreas, the islets were recovered for 2 hours in RPMI 1640 
medium (Gibco, Grand Island, NY) with 10% fetal bovine serum, 2 mM glutamine, 11.1 mM 
glucose, 1% PenStrep, and incubated at 37C in a 5% CO2 humidified incubator. Different doses 
of ebselen, Na2SeO3, NAC, or H2O2 were added into the culture medium, and islets were treated 
for six or twelve hours. Islets were then washed with HBSS buffer three times before transferred 
to protein lysis buffer for immunoblotting analysis.  
 
Drug Administration 
WT and OE mice were fasted overnight for eight hours before each administration. DQ was 
prepared in phosphate buffer, while STZ (Sigma-Aldrich, St. Louis, MO) was prepared in citrate 
buffer solution immediately before intraperitoneal (i.p.) administration. Mice were i.p. injected 
with DQ (24 g per g body weight), STZ (150 g per g of body weight), or saline (10 l per g of 
body weight). After 48h, the mice were euthanized by CO2 inhalation. Plasma and pancreas were 
collected and plasma glucose, pancreatic REG2 level, and pancreas morphology were estimated.  
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REG2 Expression and Purification 
The NOD mouse Reg2 gene (G22 to A173) was expressed with an N-terminal hexahistidine tag 
in Escherichia coli using a pQE-30 series vector (Qiagen, Valencia, CA). It is a gift from Dr. 
Werner Gurr (Gurr et al., 2007). Cells grown in LB media (100 µg/mL ampicillin, 25 µg/mL 
kanamycin) were induced with 1 mM IPTG, then lysed by sonication in lysis buffer (100 mM 
NaH2PO4, 10 mM Tris-HCl, 8 M urea, pH 8.0).  The clarified lysate was passed over an Ni-NTA 
agarose (Qiagen, Valencia, CA) column, washed with lysis buffer at pH 6.3, and REG2 eluted as 
a single peak with lysis buffer at pH 3.8.  The affinity purified REG2 was further purified by ion-
exchange chromatography using Macro-Prep high S (Bio-Rad, Hercules, CA) using a linear 
gradient from 0 to 1 M NaCl in 50 mM Na-acetate, 8 M urea, pH 5.0.  REG2 was dialyzed 
against 50 mM Na-acetate, 4 M urea, pH 5.0 for studies. 
 
The same Reg2 gene was also expressed in the native form (without a hexahistidine tag) in the 
yeast Pichia pastoris GS200. To express REG2 without non-native amino acids at the N-
terminius, the gene was cloned flush with the Kex2 cleavage site of a modified alpha-factor 
secretion signal peptide in the pPIC9 vector (Invitrogen, Carisbad, CA), and transformed into 
yeast using electroporation (BTX, Holliston, MA). After induction in BMMY for 4.5 days, the 
clarified supernatant was brought to 60% saturation with ammonium sulfate to precipitate the 
REG2. The precipitate was dissolved in 50 mM Na-acetate, pH 4.0, then dialyzed against the 
same buffer, after which REG2 was precipitated.  The precipitate was dissolved in 50 mM Tris-
HCl, pH 7.6, then subjected to ion-exchange chromatography using Macro-Prep high Q (Bio-
Rad, Hercules, CA) using a 0 to 1 M NaCl linear gradient in the same buffer. The REG2 
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containing fractions were pooled, concentrated by ammonium sulfate precipitation, then 
dissolved in and dialyzed against PBS, pH 7.4. 
 
Recombinant REG2 Protein Administration 
Both REG2 proteins were filter sterilized using a 0.2 µm syringe filter. The protein 
concentrations were measured using the BCA protein assay kit (Thermo Scientific, Rockford, 
IL), after which REG2 was frozen in aliquots at -80°C. For a short-term study, 2-6 g/g REG2 
protein was i.p. administrated into WT or OE mice. After 15 minutes, glucose tolerance test 
(GTT) and GSIS tests were performed. For a long-term study, 2-6 g/g REG2 protein was daily 
i.p. injected into 1-year-old OE mice for 2 weeks. Fasting body weight, blood glucose, plasma 
insulin and plasma triglyceride (TG) were measured every 7 days. GSIS, GTT, and insulin 
tolerance test (ITT) were performed before and after 14 days’ injection.  
 
GTT, GSIS, ITT and TG Measurements 
For the GTT, after an overnight fasting (approximately 8 hours), mice were i.p. administrated 
with a sterile solution of glucose at a final concentration of 1 g/kg body weight. Blood glucose 
levels were measured from blood drops of each mouse tail at 0, 15, 30, 60 and 120-minute time 
points using the glucometer and accompanying strips (Bayor Contour, Tarrytown, NY). For the 
GSIS, a capillary tube of blood was taken from each mouse following glucose challenge at the 0, 
15, 30 and 60-minute time points. The blood samples were transferred into individual centrifuge 
tubes and then centrifuged at 4C at 2000 RPM for 5 minutes. The clear plasma layer was 
collected and measured for insulin by using a rat/mouse insulin ELISA kit (Crystal Chem, 
Downers Grove, IL). For the ITT, the fasted mice were i.p. injected with a sterile solution of 
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insulin (Eli Lily, Indiannopalis, IL) at a final concentration of 1 U/kg body weight. Blood 
glucose was measured from blood drops of each mouse tail by using glucometer and 
accompanying strips (Bayor Contour, Tarrytown, NY), following insulin challenge at the 0, 30, 
60, 120, 180 and 240-minute time points. For TG measurement, the fasted tail blood samples 
were collected and transferred into individual centrifuge tubes and then centrifuged at 4C at 
2000 RPM for 5 minutes. The clear plasma layer was collected and measured for the 
concentration of TG using a TG kit (Wako Chemicals, Richmond, VA). 
 
Statistical Analysis  
Values were expressed as mean  SE. Significance was defined as P  0.05. The most of 
statistical comparisons between each group were performed by using one way ANOVA. In some 
experiments Dunnett’s test was used. Statistics was calculated using SAS 6.11 software (SAS 
Institute, Cary, NC).  
 
2.4 Results 
2.4.1 REG2 Was Mainly Expressed in Pancreas and Was Depleted in OE Islets 
To study the tissue distribution of REG2 protein in 6-month-old WT male mice, we collected 
fresh tissues from the mice and measured the REG2 protein level with the immunoblotting 
method. Strikingly, we observed that the REG2 level was 160 times higher in the pancreas than 
in the liver (P  0.05), while REG2 levels in the spleen, stomach, intestine, and testis were 
similar to those in the liver (Fig. 2.1A, B). The kidney, brain, lung, muscle, and heart showed 
16.5%, 9.4%, 5.1%, 17.9%, and 13.3% of REG2 level, respectively (P  0.05), when compared  
 
31 
 
 
  
 
 
A. 
B. 
C. 
 
32 
 
 
  
D. 
E. 
F. 
 
 
 
33 
 
 
 
 
 
 
 
FIGURE 2.1 REG2 protein level in different tissues and islets. 
(A, B) Immunoblotting analysis of REG2 protein level in different tissues of WT mice, and the 
quantification of the band densities by Image J software. (C) REG2 immunostaining of islets (brown 
color) in representative pancreatic sections from a WT mouse. (D, E) Immunoblotting analysis of REG2 
level in WT and OE islets, and the quantification of the band densities by Image J software. (F) 
Immunoprecipitation of endogenous REG2 from WT and OE pancreas, and Immunoblotting analysis of 
REG2 protein. Data presented as mean ± SE (n = 3 to 4 for panels B, n=4 for panels E). Means for a 
given protein without sharing a common letter differ (* P  0.05 vs. WT). 
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to the liver (Fig. 2.1A, B). The REG2 levels in white adipose tissue and plasma were too low to 
be detected by the immunoblotting approach (Fig. 2.1A, B). The immunohistochemistry analysis 
for the WT pancreas showed that REG2 was mainly expressed in the islets rather than in the 
exocrine pancreas (Fig. 2.1C). As we observed diminished Reg2 mRNA levels in OE islets 
spanning different ages (Fig. 1.5B), we used immunoblotting and immunoprecipitation 
approaches to compare the endogenous REG2 protein expression in WT and OE islets. In the 
comparison with WT islets, we confirmed the depleted endogenous REG2 protein level in OE 
islets (Fig. 2.1D, E). We also observed that the endogenous pancreatic REG2 protein level pulled 
down by REG2 antibody was dramatically decreased in OE islets (Fig. 2.1F).  
 
2.4.2 Reduced ROS Level Decreased REG2 Protein Production in Islets  
Because Reg2 was implied as a stress-induced protein (Huszarik et al., 2010; Lu et al., 2006; 
Zhong et al., 2007), we hypothesize that oxidative stress serves as the mediator of the diminished 
REG2 by GPX1 overproduction in islets. To test this hypothesis, we examined the REG2 protein 
change in islets after treating them with various chemicals that can alter their intracellular ROS 
level. To decrease their intracellular ROS level, isolated islets were treated with antioxidants 
such as ebselen, Na2SeO3, or NAC, and the REG2 protein change was estimated at the end of the 
study. Ebselen serves as a GPX1 mimic and a potent scavenger of H2O2 (Müller et al., 1984). 
Na2SeO3.is an inorganic form of Se that can increase GPX1 activity. NAC enhances GSH 
synthesis to neutralize H2O2. After 12 hours of 100 M ebselen, 100 nM Na2SeO3, or 6 mM 
NAC treatment, a significant decrease in REG2 levels was observed in both WT and OE islets 
(Fig. 2.2A, B, C). It was noteworthy that OE islets shoed more reduction in REG2 levels than 
WT islets after 50 M ebselen, 50 nM Na2SeO3, or 3 mM NAC treatment (Fig. 2.2A, B, C).   
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FIGURE 2.2 Effects of oxidative stress on islet REG2 protein production in vitro. 
REG2 protein level in WT and OE islets after (A) 12 hours of  50 and 100 M ebselen treatment; (B) 12 
hours of  50 and 100 nM Na2SeO3 treatment; (C) 12 hours of 3 and 6 mM NAC treatment, and  (D) 6 
hours of  25 and 50 M H2O2 treatment.. Data presented as mean ± SE (n = 10 to 11 for panels A, B and 
C, n = 5 for panels D). Means for a given measure without sharing a common letter differ (* P  0.05 vs. 
control (CTRL)).   
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2.4.3 Increased ROS Level Induced REG2 Protein Production both in Vitro and in Vivo  
To increase intracellular ROS levels, oxidative stress inducers H2O2, DQ, and STZ were used to 
treat either islets or mice. H2O2 can diffuse across biological membranes and react with cellular 
components (Thannickal and Fanburg, 2000). DQ is an herbicide that is also associated with 
cellular production of ROS, including H2O2, ·O2
-
, and ·OH (Farrington et al., 1973; Stancliffe 
and Pirie, 1971). STZ is a glucosamine-nitrosourea compound that resembles glucose, as it is 
transported into the β cells by GLUT2 and damages their DNA fragmentation through H2O2 
generation (Takasu et al., 1991; Wang and Gleichmann, 1998). 
 
Firstly, islets were treated with 0, 25, or 50 M H2O2 for 6 hours, and REG2 protein expression 
was determined. After 50 M H2O2 treatment, WT and OE islets showed a 78.1% and 41.9% 
increase of REG2 protein level respectively (P0.05) in comparison to their own control group, 
while there was no significant change after the 25 M H2O2 treatment (Fig. 2.2D). Next, mice 
were injected with buffer, DQ, or STZ, and plasma glucose concentration, REG2 levels, and 
morphological changes of pancreas were estimated 48 hours after the injection. Both the WT and 
OE pancreas showed oedema with enlarged secretory granules and atrophic rough endoplasmic 
reticulum on the basal side, while the islet cells exhibited a slightly irregular shape, pycnosis and 
vacuoles, or vesiculation after DQ or STZ injection (Fig. 2.3A). Pancreatic endocrine damage 
was corroborated by the markedly decreased insulin level, which is reflected by elevated blood 
glucose (Dirice et al., 2011). After 48 hours of treatment, WT mice showed 123.6% higher 
plasma glucose (P0.05) as compared with the control (Fig. 2.3B, left panel), but OE mice only  
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FIGURE 2.3 Effects of oxidative stress on pancreatic REG2 protein production in vivo.  
DQ and STZ were injected intraperitoneally into mice at concentrations of 24 mg and 150 mg per kg of 
body weight, respectively. Saline injection of 10 ul/ g of body weight served as control. After 48 hours, 
mice were sacrificed and plasma and pancreas were collected. (A) H&E staining of pancreas sections 
from WT and OE mice (10X magnification). (B) Plasma glucose level in WT and OE mice. (C, D) REG2 
protein level in the pancreas was analyzed by using Western blot and the band densities were quantified 
by Image J software. Data presented as mean ± SE (n = 5 to 6 for panels B and D) and the image (A) was 
a representative of 4 independent experiment. Means for a given measure without sharing a common 
letter differ (* P   0.05 vs. CTRL). 
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showed an increased trend in plasma glucose as compared with the control (Fig. 2.3B, right 
panel). Most importantly, both WT and OE pancreas exhibited a significant increase of REG2 
level after DQ or STZ injection (Fig. 2.3 C, D). Collectively, these results demonstrated that 
REG2 protein expression was induced by oxidative stress. 
 
2.4.4 Acute Injection of REG2 Decreased Glucose Tolerance and GSIS in OE Mice  
A low level of REG2 in OE islets also directed us to investigate the role of REG2 as an 
important mediator of metabolic disorders in OE mice. To examine the effect of exogenous 
REG2 on glucose homeostasis, we expressed and purified the mouse REG2 protein from P. 
pastoris GS200 and confirmed the protein expression (Fig. 2.4A). In order to study the role of 
REG2 in the OE T2DM-like phenotypes, we administered the exogenous REG2 protein to WT 
and OE mice and examined the blood glucose and insulin changes. To determine the acute effect 
of REG2 on glucose tolerance and GSIS, WT and OE mice were injected with 2 g/g REG2, and 
after 15 minutes, they were challenged with 1 g/kg glucose. Blood glucose and plasma insulin 
level were measured at different time points. In comparison to the PBS-injected OE mice, the 
REG2-injected OE mice showed glucose intolerance (Fig. 2.4C) and decreased GSIS (Fig. 
2.4D). However, WT mice did not show a significant response to REG2 injection (Fig. 2.4B). To 
summarize, these in vivo studies showed the acute inhibitory role of exogenous REG2 
administration on GSIS in OE mice.  
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FIGURE 2.4 Effects of short-term exogenous REG2 pre-injection on GSIS in vivo. 
(A) The recombinant mouse REG2 protein was expressed in P. pastoris GS200, purified by gel filtration 
and ion exchange chromatography, and then redissolved in PBS buffer. The expression of REG2 protein 
was confirmed by immunoblotting analysis. (B, C) Effect of pre-injected REG2 on GTT results: 2 g 
REG2 protein/g body weight was i.p. injected into WT and OE mice, 10ul PBS/g body weight injection 
group served as control. After 15 minutes, 1 g/kg glucose was i.p. injected into the mice. Blood glucose 
was measured at different time points. (D) Effect of pre-injected REG2 on GSIS in OE mice: 2 g REG2 
protein/g body weight was i.p. injected into OE mice, 10 ul PBS/g body weight injection group served as 
control. After 15 minutes, 1 g/kg glucose was i.p. injected into the mice. Plasma insulin was measured at 
different time points. Data presented as mean ± SE (n = 5 to 6 for panels B, C and D). Means for a given 
time-point without sharing a common letter differ (* P  0.05 vs. CTRL). 
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2.4.5 Long-term Administration of REG2 Protein Improved Hyperinsulinemia, 
Hyperglycemia and Hypertriglyceridemia in OE Mice  
To determine whether or not the REG2 protein is involved in the development of the T2DM-like 
phenotypes in OE mice, 1-year-old OE male mice were i.p. injected with either the recombinant 
REG2 protein (2 g/g) or PBS (10 l/g) for 14 consecutive days. Interestingly, after 14 days of 
daily exogenous REG2 administration, the fasting blood glucose, plasma insulin levels, body 
weight and plasma triglyceride (TG) were decreased compared with their day 0 baseline (P < 
0.05) (Fig. 2.5A, B, C and D). These parameters were also significantly lower than their PBS 
control group (P < 0.05) (Fig. 2. 5A, B, C and D). The REG2 treatment group that was subjected 
to a glucose tolerance test exhibited glucose intolerance (Fig. 2.5E, F) and decreased GSIS (Fig. 
2.5G, H), as compared with the control group subjected to the same test. However, the REG2 
treatment group and PBS control group did not show any differences in insulin tolerance (Fig. 
2.5I, J), indicating that the glucose intolerance by REG2 administration was caused by decreased 
insulin secretion. 
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FIGURE 2.5 Effects of long-term daily REG2 injection on T2DM-like phenotypes in 1-year-old OE 
mice. 
Effects of two-week daily REG2 protein i.p. injection (2 g REG2 protein/g body weight) on (A) fasting 
body weight, (B) blood glucose, (C) plasma insulin, (D) plasma TG, (E, F) body glucose tolerance 
absolute values (left) and % of initial (right) (1 g glucose/kg), (G, H) GSIS absolute values (left) and % of 
initial (right) (1 g glucose/kg), (I, J) body insulin tolerance absolute values (left) and % of initial (right) 
(0.5 insulin U/kg), Data presented as mean ± SE (n = 5 to 6). Means for a given measure without sharing 
a common letter differ (* P  0.05 vs. CTRL, † P  0.05 vs. initial). 
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2.5 Discussion 
Here we gained new insights into the biochemical mechanisms of GPX1 overexpression-
dependent decrease of REG2 protein level in islets. We discovered the novel function of REG2 
in alleviating hyperinsulinemia, hyperglycemia, and hypertriglyceridemia in old OE mice, the 
first study that links the antioxidant system to islet regenerating proteins. 
 
The main function of GPX1 is to reduce intracellular H2O2. GSH is the substrate of GPX1 that 
participates directly in the neutralization of free radicals and reactive oxygen compounds. Reg2 
was reported to be related to acute pancreatitis (Huszarik et al., 2010; Lu et al., 2006; Zhong et 
al., 2007), and its promoter activity can also be significantly increased by glucocorticoids and IL-
6 treatment (Luo et al., 2013). Strikingly, mRNA level of Reg2 was found to be significantly 
depleted in the islets of OE mice as compared to WT mice (Fig. 1.5A, B). In addition, REG2 
expression was found to be inversely related to GPX1 expression in high-fat diet fed mice (Qiu 
et al., 2005). Based on the inverse correlation between GPX1 and REG2 and their connection to 
oxidative stress, we hypothesized that GPX1 down-regulated REG2 through ROS degradation. 
To test the hypothesis, we first studied the tissue distribution of REG2 protein in WT mice. We 
observed the highest protein expression of REG2 in the pancreas, 160 fold higher than in the 
liver and intestine, the organs that showed the second highest REG2 expression (Fig. 2.1A, B). 
This implied that the pancreas might be the main organ where REG2 expressed and functioned. 
To investigate further the distribution of REG2 in the pancreas, we used the 
immunohistochemistry approach to stain the WT pancreas section with REG2 antibody. 
Interestingly, we found that REG2 protein was mainly expressed in the islets rather than in the 
exocrine pancreatic tissues (Fig. 2.1C). We then confirmed the diminished REG2 protein 
expression in OE islets by using immunoblotting and immunoprecipitation methods (Fig. 2.1D, 
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E). These findings led us to use pancreatic islets as the in vitro model to study the regulation and 
function of REG2 protein. By treating islets with various chemicals that alter intracellular ROS 
levels, we demonstrated that REG2 protein expression was decreased by antioxidant treatments 
and increased by H2O2 treatment, relative to their respective controls (Fig. 2.2A, B, C and D). 
We then injected mice with oxidative stress inducers to study the change of REG2 protein in 
vivo. 48 hours after STZ or DQ administration, we observed the up-regulated REG2 expression 
in the pancreas as compared to the control (Fig. 2.3C, D). This result is also supported by a study 
in which STZ injections significantly up-regulated REG2 in the pancreas (Lu et al., 2006). 
Therefore, the above REG2 expression profile studies demonstrated that REG2 protein in islets 
was induced by oxidative stress, and that Se-dependent GPX1 inhibited REG2 expression by 
modulating intracellular ROS level. 
 
OE mice serve as a REG2-functional knockout model since REG2 is depleted in the OE islets, so 
it is interesting to investigate whether or not the decreased REG2 contributes to the metabolic 
disorders in OE mice. To address this question, we made recombinant REG2 protein and 
performed short-term and long-term injection studies. Firstly, we administrated the purified 
exogenous REG2 protein into WT and OE mice, and after 15 minutes, we challenged the mice 
with 1 g per kg body weight glucose. The OE mice showed glucose intolerance and decreased 
GSIS after REG2 injection, while WT mice did not exhibit any significant differences compared 
with their own PBS-injected group (Fig. 2.4B, C and D). This study presented the acute 
inhibitory role of REG2 on GSIS in OE mice. In light of the finding, we further studied the 
chronic role of the exogenous REG2 administration on the metabolic disorders in this mouse 
model. We injected the 1-year-old OE mice daily with 2 g/g recombinant REG2 protein and 
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monitored the change of metabolic parameters after two weeks. Exogenous REG2 administration 
alleviated most of the metabolic disorders in OE mice except for the insulin resistance. In 
comparison with the PBS-injected group and their own initial baseline, the REG2-injected group 
showed a significant decrease in body weight, plasma glucose, plasma insulin, and plasma TG 
(Fig. 2.5A, B, C and D). GSIS and glucose tolerance were also decreased in the REG2-injected 
group as compared to the PBS-injected group (Fig. 2.5 E, F, G and H). However, we did not 
observe any change in insulin tolerance after REG2 injection (Fig. 2.5I, J). 
 
These findings, coupled with the fact that REG2 was identified as a down-stream signaling 
partner of GPX1, as well as the novel function of REG2 in rescuing the metabolic syndrome in 
OE mice, strongly suggest that REG2 plays an important role in the development of T2DM-like 
phenotypes in OE mice. In addition, it provides new insights into a therapeutic strategy for 
T2DM, in particular the prediabetic state in human. 
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CHAPTER 3 
Novel Molecular Mechanisms of REG2 in Regulating  
Glucose-Stimulated Insulin Secretion 
3.1 Abstract 
In Chapter 2, we found that REG2 improved hyperinsulinemia, hyperglycemia, and 
hypertriglyceridemia in OE mice. To further confirm the role of REG2 in insulin secretion and to 
investigate the underlying mechanisms, we examined the regulation of insulin secretion by 
native and mutant forms of REG2 protein in vitro. We also set out to indentify the unknown 
REG2 binding partners by using protein-protein interaction approaches. We found that REG2 
treatment decreased insulin secretion stimulated by glucose (P  0.05), but did not change the 
insulin secretion stimulated by either potassium chloride (KCl) or arginine in OE islets. In 
addition, REG2 mutant 1 (M1) with mutations in C-type lectin domain failed to suppress GSIS, 
while REG2 mutant 2 (M2) with mutations in six acidic residues inhibited GSIS (P  0.05) in 
OE islets. To determine the REG2 downstream signaling, we found that REG2 treatment 
decreased the expression of genes involved in glucose metabolism or Ca
2+
 homeostasis, but not 
the genes related to insulin synthesis. REG2 treatment also decreased GLUT2 protein 
expression, GK protein activity, and islet mitochondria membrane potential, and also increased 
levels of UCP2 protein level (P  0.05). In search of the REG2 binding partners, we studied the 
interaction between REG2 with four membrane proteins and eight cytosolic proteins. However, 
we have not yet identified the direct binding proteins of REG2. In conclusion, we have found 
REG2 inhibition of insulin secretion in OE islets to be a glucose-dependent process, and this 
work suggested that REG2 C-type lectin domain was involved as well. Further investigation is 
needed to identify the REG2 binding proteins.  
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3.2 Introduction 
Glucose is an important secretagogue for insulin secretion. Glucose usage in  cells is mainly 
determined by glycolysis and cellular level of GK and glucose (Matschinsky, 1996), as glycogen 
synthesis and pentose-phosphate shunt is very limited in a  cell (Schuit et al., 1997). The key 
regulators of GSIS are tightly linked to glucose and mitochondrial metabolism (Malmgren et al., 
2009). When the level of blood glucose rises, glucose is rapidly transported into the cell by 
GLUT2. The intracellular glucose is further phosphorylated by GK, which initiates glycolysis 
and oxidative phosphorylation (German, 1993; Henquin, 2000). This results in an increased 
ATP/ADP ratio (Henquin, 2000), closure of ATP-sensitive K
+
 channels (Ashcroft et al., 1984; 
Cook and Hales, 1984), opening of the voltage-sensitive Ca
2+
 channels, and an influx of Ca
2+
 
that leads to insulin exocytosis (Kelly et al., 1991). In mitochondria, a proton circuit across the 
mitochondrial inner membrane drives oxidative phosphorylation, coupling substrate oxidation 
and ADP phosphorylation, while UCP2, one of the members of the larger family of 
mitochondrial anion carrier proteins, contributes to proton leak in the mitochondria inner 
membrane, decreasing ATP production and attenuating insulin secretion in pancreatic β cells 
(Krauss et al., 2002; Lowell and Shulman, 2005). 
 
KCl stimulates insulin secretion directly through membrane depolarization, which results in the 
opening of voltage-dependent Ca
2+
 channels, increasing cytosolic Ca
2+
 concentration and 
activation of effector systems responsible for exocytosis of insulin (Ohsugi et al., 2004). 
Arginine is another insulin secretagogue that is a cation at physiological pH and can also directly 
serve as a depolarizing agent (Sener et al., 2000; Thams and Capito, 1999). It stimulates Ca
2+
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influx and insulin granules exocytosis independently of KATP channel activity in  cells (Sener et 
al., 2000).  
 
The REG family of genes belongs to the Ca
2+
-dependent lectin (C-type lectin) gene superfamily 
(Lasserre et al., 1994). They are a group of secretory proteins (Bacon et al., 2012; Carrère et al., 
1999; Keel et al., 2009; Orelle et al., 1992; Zenilman et al., 2000) and were proposed to interact 
with its own putative receptors at the plasma membrane of the cells. To date, there has been only 
one Reg receptor identified, exostoses tumor-like gene 3 (EXTL3). EXTL3 was identified as the 
Reg1 receptor by Kobayoshi et al., who probed an expression library of rat pancreatic islets with 
rat Reg1 and isolated a cDNA that showed over 97% homology to the human EXTL3 
(Kobayashi et al., 2000; Van Hul et al., 1998). hReg1 was later found to colocalize with 
EXTL3 at the plasma membrane of PC12 cells, hippocampla neurons, and hippocampic CA 
areas and cortex (Acquatella-Tran Van Ba et al., 2012; Marchal et al., 2012), and regulate neurite 
elongation through its putative membrane receptor EXTL3 (Acquatella-Tran Van Ba et al., 
2012). Another Reg member, Reg3 was also found to be related to EXTL3. Human Reg3 
(hReg3) was demonstrated to accelerate translocation of the EXTL3 protein to the nuclear 
subcellular fraction in human PANC-1 cells (Levetan et al., 2008). hReg3 was also reported to 
be able to interact with EXTL3 in keratinocytes to mediate epidermal hyperproliferation (Lai et 
al., 2012). 
 
This study was conducted to confirm the inhibitory role of REG2 on insulin secretion observed 
in vivo from Chapter 2, and to further investigate the underlying mechanisms. We firstly 
examined the regulation of insulin secretion by native and mutant forms of REG2 protein in 
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vitro. We then studied the gene and protein change of the related key regulators after REG2 
treatment in vitro. Thirdly, we set out to identify the unknown REG2 binding partners by using 
AP-TAG binding assay, immunoprecipitation and mass spectrometry, as well as yeast two 
hybrid approaches.  
 
3.3 Materials and Methods 
Plasmid Construction, Expression and Purification of REG2 Mutant Proteins 
The NOD mouse Reg2 cDNA (NM_009043, G22 to A173) was a gracious gift of Dr. Gurr (Gurr 
et al., 2007).  The Reg2 gene was cloned flush with the Kex2 cleavage site of a modified alpha-
factor secretion signal peptide (gamma) in the pPIC9 vector (Invitrogen, Carisbad, CA) using 
XhoI and EcoRI restriction sites.  This allowed expression of REG2 without non-native amino 
acids at the N-terminus. This construct and vector pPICZalphaC were digested with BstBI and 
EcoRI, then the gamma-Reg2-containing fragment was ligated into the pPICZ vector backbone 
to create Reg2/pPICZgammaC. Reg2 mutants were created by site-directed mutagenesis of the 
Reg2/pPICZgammaC construct. Mutants were created through Touchdown PCR using 
mutagenic forward and reverse primers (Integrated DNA Technologies, Coralville, IA) with 
PrimeSTAR HS DNA polymerase (Takara, Otsu, Shiga, Japan) followed by Dpn1 digestion of 
parental DNA template (TABLE D.).  Chemically competent E. coli were transformed via heat 
shock.  Sequence verification was performed by Big Dye Terminator chemistry at the Cornell 
Biotechnology Resource Center. Isolated plasmid was transformed into the yeast Pichia pastoris 
GS200 using electroporation (BTX, Holliston, MA) and the mutants expressed and purified as 
for the WT REG2. 
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Static System for Insulin Secretion in Primary Islets 
Primary islets were isolated from WT and OE mice by collegenase perfusion and cultured in 
RPMI-1640 for 5 hours at 37°C in 5% CO2. Islets were then transferred to Krebs buffer with 2.8 
mM glucose at 37°C water bath, treated with 1 g/ml REG2 protein for 0.5 hour and then with 
30 mM glucose/KCL for 1 hour (treatment group). Islets without REG2 and high glucose 
treatment served as a negative control group, and the ones without REG2 but with high glucose 
treatment served as a positive control group. Medium supernatant was collected before (0 min) 
and after (60 min) glucose/KCL treatment. Insulin concentration in the supernatant was 
measured by using ELISA kit (Crystal Chem, Downers Grove, IL). After the 1.5 hr treatment, 
islets were collected and homogenized in protein lysis buffer for further experiment analysis.  
 
Perifusion System for Insulin Secretion in Primary Islets 
Seventy freshly isolated OE islets were placed on a nylon filter in a plastic perifusion chamber 
(Millipore, Bedford, MA). The perifusion apparatus consisted of a water bath (37°C), a fraction 
collector (Bio-Rad, Hercules, CA), and a fast protein liquid chromatography (Bio-Rad, Hercules, 
CA), which allowed programmable rates of flow and glucose concentration in the perifusion. 
The perifusate was a Krebs bicarbonate buffer (pH 7.4) containing 2.2 mmol/l Ca
2+
 and 0.25% 
BSA equilibrated with 95% O2/5% CO2, and the perifusion flow rate was 1 ml/min. For GSIS 
experiment, OE islets were perifused with 1 g/ml/min of REG2 or REG2 mutants or PBS for 15 
minutes, followed by a ramp of 0-50 mM glucose per min. The maximal islet secretion response 
was tested at the end of each experiment with 30 mM KCL after washout of glucose. For KCL- 
or Arginine- stimulated insulin secretion experiments, OE islets were perifused with 1 g/ml/min 
of REG2 for 15 minutes, followed by a ramp of 0-30 mM KCL or 0-25 mM arginine per min 
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respectively. Fractions were collected for insulin detection by using ELISA kit (Crystal Chem, 
Downers Grove, IL).   
 
Quantitative Real Time PCR Analysis 
Total RNA was extracted from the primary islets by using the Trizol reagent (Invitrogen, 
Carisbad, CA). The concentration and integrity of diluted samples were determined using a 2100 
Bioanalyzer (Agilent Technologies, Santa Clara, CA), and 1 g (10 l) of RNA was reverse 
transcribed into cDNA using 1 l each of dNTP and Oligo(dT) in a 5 minute 65C reaction using 
a thermocycler, followed by 4 l 5x First Strand Buffer, 2 l 0.1 M DTT, 1 l RNase OUT, and 
1 l Superscript III at 50C for 50 min and 70C for 15 minutes. 1 l of cDNA was loaded into 
each well of 384 well qPCR plates and was reacted with 3 l ddH2O, 5 l SybrGreen PCR 
Master Mix and 0.5 l forward and 0.5 l reverse primers for 40 cycles with a Tm of 60C. -
actin was used as a reference gene and the 2^
-ddCt
 method was used for all analysis of the results 
(Schmittgen and Livak, 2008). 
 
Immunoblotting 
Islets were placed in a protein lysis buffer containing 25 mM Tris-HCl (pH 7.4), 10 mM 
Na3VO4, 100 mM NaF, 50 mM Na4P2O7, 10 mM EGTA, 10 mM EDTA, 1% Triton X-100, 5 
g/ml aprotinin, 10 nM okadaic acid, and 2 mM phenylmethylsulfonyl fluoride (PMSF). After 
homogenization on ice, cell lysate was centrifuged at 4C, 14000RPM, for 15 minutes. The 
supernatant was collected and assayed for protein quantification via BCA assay (Thermo 
Scientific, Rockford, IL). The rest supernatant was used for Immunoblotting analysis. For 
Immunoblotting, islet lysate supernatant was heated at 100C heat block for 5 minutes and 
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resolved by an SDS-PAGE gel, transferred to a nitrocellulose membrane, and blocked in a 3% 
milk/TBST solution for 1 hour. The membrane was incubated with primary antibodies (diluted in 
TBST) at 4C, overnight, washed in TBST (3 X 15 minutes), and incubated with secondary 
antibodies (also diluted in TBST) for 1 hour at room temperature. Following 3X washes in 
TBST, the signals on the membrane were detected using a Pierce ECL Immunoblottingting 
System (Thermo Scientific, Rockford, IL).  
 
Enzyme Activity Assays 
Glucokinase (GK) activity in islets and liver was measured in a coupled reaction with glucose-6-
phosphate dehydrogenase (G6PDH) through monitoring nicotinamide adenine dinucleotide 
phosphate (NADPH) production by the increased rate of absorbance at 340 nm. NADP (Sigma-
Aldrich, St. Louis, MO) was used as a coenzyme and G6PDH (Sigma-Aldrich, St. Louis, MO) 
was used as a coupling enzyme. The assay protocol is similar to that reported by Danial (Danial,  
Gramm et al. 2003). 
 
Mitochondrial Potential Measurement 
Freshly isolated OE islets were cultured in HANKS buffer containing 10mM glucose with PBS 
or 1 g/ml REG2 for 0.5 hour. JC-1 mitochondria dye (Sigma-Aldrich, St. Louis, MO) was 
added into the medium and was allowed to stain the islet mitochondria for another 20 minutes. 
Staining buffer was used to wash away the extracellular dye twice. Islets were then used to make 
slide for fluorescence microscope imaging by using Axiovert 200 M fluorescent microscope. 
Mitochondrial membrane potential was compared based on the orange color change.  
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REG2-FITC Treatment in Islets 
REG2-FITC was prepared by conjugating the purified native REG2 expressed in P. pastoris 
GS200 with fluorescein by incubation of REG2 with a ten-fold molar ratio of fluorescein 
isothiocyanate (FITC) isomer I (Sigma-Aldrich, St. Louis, MO) in 33 mM sodium carbonate, pH 
9.0 for 2 hours at 25°C in the dark. Unreacted FITC was removed by dialysis against PBS, pH 
7.4 using a 14 kDa MWCO membrane. The labeling rate was calculated to be 1.9 mol FITC/mol 
REG2 by E
0.1%
280
  of 195 and 2.59, respectively. 20 isolated islets were incubated in 150 μl Hanks’ 
balanced salt solution containing 10 mM glucose. Islets were treated with either 1 μg REG2-
FITC or 1 μg REG2-FITC and 5 μg REG2 for 1, 3, and 15 hours. Untreated islets served as a 
control. Islets were collected, washed 3~6 times with PBS and put into a 96-well plate with 50 l 
PBS in each well.  Fluorescent microscopy was performed using an Axiovert 200 M fluorescent 
microscope.  
 
Immunoprecipitation (IP) and Mass Spectrometry 
Fresh islets/pancreas were collected from WT mice and homogenized in the protein lysis buffer 
by using a homogenizer. The cell lysate was then centrifuged at 11,000rpm for 10 minutes, 
supernatant was collected for the IP study.  Incubate 500ug WT islet/pancreas whole cell lysate 
was incubated with protein G beads (Santa Cruz, Dallas, TX) with/without REG2 antibody at 
4C overnight. Protein G beads with just REG2 antibody served as negative control. The next 
day, the beads were washed five times using washing buffer and the proteins were eluted by 
using SDS-PAGE loading buffer to incubate at 100C for 5minutes. The samples were then 
centrifuged, the supernatant was loaded into SDS-PAGE gels. Silver staining/Sypro Ruby 
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staiming were used to stain the SDA-PAGE gels. The bands were excised and sent for mass 
spectrometry analysis. (Cornell Proteomics Center, Ithaca, NY).  
 
AP-TAG Binding Assay 
HEK293T cells were seeded at 1e5 per/ml the day before transfection. PEI was then used to 
transfect pre-made AP vectors into the HEK293T cells. The cells were incubated in DMEM 
medium with 10% FBS, 1% PenStrep at 37C incubator with 95% CO2. After 3 to 4 days, 
conditioned media (CM) was collected for binding assay. AP activity in the CM was measured 
by using PNPP fast tablet (Sigma-Aldrich, St. Louis, MO): 1 tablet into 20 ml H2O. 100 ul PNPP 
was added into a 96 well assay plate, together with 1-5 l of CM, OD value was recorded at 
405nM every minute. AP concentration was calculated by using the equation: AP concentration 
(nM) = change in OD/minute *3000/ l added. -TC3 cells were transfect with plasmid DNA of 
receptor of interest by using PEI. After 48 hours of incubation, the cells were washed with HBH 
twice and then incubated with CM for 2 hours at room temperature. Cells were further washed 
with ice cold HBH for three times and then fixed with 3.7% formaldehyde in PBS for 20 
minutes. After fixing, cells were washed with HBH buffer again and the plates were put in 67
o
C 
incubator for 5 hours. After deactivating the endogenous AP activity, cells were washed with AP 
buffer and developed with NBT (70 l; stock 50 mg/ml in 70% DMF) and BCIP (70 l; stock 
25mg/ml in H2O) in 10 ml AP buffer. Ligand-receptor binding will be observed in the color of 
purple.  
 
Yeast Two Hybrid 
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Primers were designed for the four BD genes: Reg2, Ntrl, Clect, Ctrl, and eight AD genes: Cars, 
Gsn, HnrnpU, Vcp, Pkc, Pi3k, Nckap1, and Sec23b. PCR method was used to amplify the gene 
from mouse islets or liver cDNA. Restriction enzymes: SalI, EcoRI, NheI and BamHI and T4 
ligase (Promega, Madison, WI) were used to digest and ligate the genes into pAD-GAL4-2.1 
Phagemid vector or pBD-GAL4 Cam phagemid vector (Agilent Technologies, Santa Clara, CA). 
The pBD/pAD plasmids were then transformed into DH5 competent cells. The next day, the 
plasmids were extracted and purified by using Mini-prep kit (Qiagen, Valencia, CA). The pBD 
and pAD plamids were further tranformed into freshly prepared yeast competent cells (PJ69-4A 
and PJ69-4, respectively). After mating the transformed yeast cells overnight, the mixture were 
plated on SC-Leu-Trp-His, SC-Leu-Trp-Ade or SC-Leu-Trp-His-Ade mutant plates for protein-
protein interaction screening.  
 
Statistical Analysis 
Values were expressed as mean  SE. Significance was defined as P  0.05. The most of 
statistical comparisons between each group were performed by using one way ANOVA. In some 
experiments Dunnett’s test was used. Statistics was calculated using SAS 6.11 software (SAS 
Institute, Cary, NC). Area-under-the-curve (AUC) for insulin secretion analysis was calculated 
by using Kaledagraph 3.l6 software (Synergy Software, Reading, PA).  
 
3.4 Results 
3.4.1 REG2 Inhibited GSIS in OE Islets  
To confirm the inhibitory role of REG2 in GSIS in vivo, we used both static and perifusion 
systems to study the GSIS change after REG2 treatment in vitro. In the static study, OE islets 
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pretreated with REG2 exhibited a 59.4 % reduction (P  0.05) of insulin secretion stimulated by 
30 mM glucose as compared to the control group (Fig. 3.1A). In the perifusion study, OE islets 
were pretreated with REG2 protein or PBS for 15 minutes and followed by a 0-50 mM glucose 
ramp treatment. OE islets pretreated with REG2 showed suppressed insulin secretion dynamics 
in a glucose dose-dependent manner as compared to the PBS pretreated group (Fig. 3.1B). 
 
3.4.2 No Effect of REG2 Protein on KCl-Stimulated or Arginine-Stimulated Insulin 
Secretion 
The next question was whether the inhibitory role of REG2 solely depended on glucose 
metabolism. To understand this, we used KCl to stimulate insulin secretion from OE islets. 
Interestingly, REG2 did not decrease static KCl-stimulated insulin secretion (KSIS) in OE islets 
with the presence of 2.8 mM glucose (Fig.3.1C). Without adding extra glucose in the medium, 
the dynamics of insulin secretion was not affected in the REG2-pretreated islets during 0-30 mM 
KCl ramp (Fig. 3.1D). Instead, KCl treatment showed some increased trend in insulin secretion 
in REG2-pretreated OE islets. We also tested the effect of REG2 protein on arginine-stimulated 
insulin secretion in OE islets. We pretreated OE islets with REG2 protein for 15 minutes, 
followed by 0-25 mM L-arginine ramp treatment. We found that there was no significant change 
of insulin secretion between REG2- and PBS-pretreated groups (Fig. 3.1E).  
 
3.4.3 Different Effects of REG2 Mutants on GSIS in OE Islets 
In order to understand which functional domains of REG2 might be involved in inhibition of 
GSIS in OE islets, we designed, expressed and purified two REG2 mutant proteins. Three amino  
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FIGURE 3.1 Effects of REG2 protein treatment on insulin secretion in vitro. 
Effects of REG2 pretreatment on GSIS in OE islets using (A) the static incubation and (B) perifusion 
system. Effects of REG2 pretreatment on KCl-stimulated insulin secretion in OE islets using (C) the static 
incubation and (D) perifusion system. (E) Effects of REG2 pretreatment on arginine-stimulated insulin 
secretion in OE islets using the perifusion system. (F) Predicted three-dimensional protein structures for 
REG2 mutant 1 (M1) and REG2 mutant 2 (M2). Effects of (G) M1 and (H) M2 on GSIS in OE islets by 
using perifusion system. Data presented as mean ± SE (n = 4-5). Means for a given measure at a given 
time-point without sharing a common letter differ (P < 0.05). Area under the curve (AUC) was analyzed 
by using Kaledagraph software.  
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acid residues in the C-type lectin domain of REG2 (Walker et al., 2004), were mutated to 
alanines (G142A, K157A, and D158A) (Fig. 3.1F). We named it REG2 M1. The acidic residues 
potentially involved in CaCO3 crystal binding (Bertrand et al., 1996) in REG2 were mutated to 
glycines (E59G, D60G, E66G, D158G, E159G, and E162G) (Fig. 3.1F). We called it REG2 M2. 
We treated OE islets with these purified mutant proteins and examined their influence on GSIS. 
Interestingly, compared to PBS pretreatment, REG2 M1 pretreatment did not decrease GSIS in 
OE islets (Fig. 3.1G), while REG2 M2 pretreatment decreased GSIS (P  0.05) in a glucose-
dependent manner (Fig. 3.1H). 
 
3.4.4 REG2 Suppressed Genes and Proteins Involved in GSIS in OE Islets 
We then asked how genes changed in response to the observed inhibitory effects of REG2 
treatment on GSIS. We treated OE islets with 1 g/ml REG2/PBS and 30 mM glucose for 0, 15, 
30 or 60 minutes, respectively, and examined the expression of genes related to glucose 
metabolism, mitochondrial metabolisms, free calcium homeostasis, as well as insulin synthesis. 
We observed a down-regulation of Glut2, Gk1 after 15, 30 or 60 min (P  0.05) (Fig. 3.2A, B), a 
decrease of pyruvate kinase, Pklr, and ATP-synthase subunit, Atp5b, after 30 or 60 min (P  
0.05) (Fig. 3.2C, D), but no change of Ucp2 gene after REG2 treatment (Fig. 3.2E). We 
determined  a downregulation of  voltage dependent L-type calcium channels, Cav1.2 and  
Cav1.3,  and protein kinase C, Prkcb, after 30 or 60 min of  REG2 treatment (P  0.05) (Fig. 
3.2F, G, H). However, we were not able to detect any change in genes related to insulin 
synthesis, such as Ins1, Foxa2, Beta2 and Pdx1 (Fig. 3.2I, J, K, L). In addition to gene changes, 
we further tested changes in protein level of the key regulators of GSIS. We found that REG2 
down-regulated GK activity (P  0.05) (Fig. 3.2M) and decreased mitochondrial membrane  
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FIGURE 3.2 Effects of REG2 treatment on the expression of glucose metabolism- and Ca
2+
 homeostasis- 
related genes in OE islets. 
OE islets were treated with 1 g/ml REG2 protein together with 30 mM glucose for 15, 30 and 60 
minutes. Islets were collected for mRNA analysis by qPCR (A-E) Glucose metabolism-related gene 
expression: Glut2, Gk1, Pklr, Atp5b and Ucp2 were analyzed. (F-H) Ca
2+
 homeostasis-related gene 
expression: Cav1.2, Cav1.3 and Prkcb were analyzed. (I-L) Insulin synthesis-related gene expression: 
Ins1, Beta2, Foxa2 and Pdx1 were analyzed. (M) OE islets were treated with 1 g/ml REG2 protein for 
30 minutes following treatment with 30mM glucose for 60 minutes. Islets were collected to estimate GK 
protein activity. (N) OE islets were treated with 1 g/ml REG2 protein together with 10 mM glucose for 
30 minutes. Islets were further treated with JC-1 mitochondria fluorescent dye for 20 minutes and 
alterations of mitochondria membrane potential were detected (O) OE islets were treated with 0.5, 1, 5, 10 
g/ml REG2 protein for 30 minutes, and following treatment with 30 mM glucose for 60 minutes. Islets 
were collected and GLUT2, UCP2, PDX1 and -ACTIN protein levels were analyzed by 
immunoblotting. Data presented as mean ± SE (n = 5) and the image (M) was a representative of 3 
independent experiment.  Means for a given measure without sharing a common letter differ (* P  0.05 
vs. CTRL).  
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potential (Fig. 3.2N). REG2 also dose-dependently decreased GLUT2 protein expression and 
increased UCP2 protein level, but not PDX1 expression (Fig. 3.2O). 
 
3.4.6 Identification of REG2 Interacting Proteins 
Because the REG proteins are secretory proteins (Bacon et al., 2012; Carrère et al., 1999; Keel et 
al., 2009; Orelle et al., 1992; Zenilman et al., 2000), and some of them can interact with the 
membrane protein EXTL3 (Acquatella-Tran Van Ba et al., 2012; Kobayashi et al., 2000; Lai et 
al., 2012; Marchal et al., 2012), we investigated whether or not REG2 could bind to EXTL3 as 
well. To determine the general binding of REG2 on cell surface, we conjugated the recombinant 
REG2 protein with fluorescein isothiocyanate (FITC) and treated WT islets with the REG2-FITC 
protein or with a mixture of REG2-FITC and unlabeled REG2 protein. Islets without treatment 
served as the control. As expected, we observed a significant increase of green fluorescence in 
the REG2-FITC-treated islets when compared with the control (Fig. 3.3A). We also detected a 
reduced FITC signal when islets were treated with the mixture of FITC labeled/unlabeled REG2 
(Fig. 3.3A), thus suggesting a competitive binding of REG2 to its potential membrane target. To 
investigate the binding of REG2 and EXTL3, we used an AP-TAG binding assay. The pAPtag-5 
vector encoding mouse Reg2 or Reg3 was created by inserting the gene between the restriction 
sites as shown (Fig. 3.3B). The constructs were transfected into HEK293T cells to make the 
conditioned medium. AP protein expression (Fig. 3.3C) and REG2 protein expression (Fig. 
3.3D) were confirmed by using the immunoblotting assay. EXTL3 were overexpressed in -TC3 
cells, and empty pcDNA3.1 vector served as the negative control (Fig. 3.3E). After a 2-hour 
binding with AP conditioned mediums, AP-REG3 showed positive binding with EXTL3, as we 
can see the cells colored dark purple (Fig. 3.3E). Neither AP-REG2 nor REG2-AP showed any  
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FIGURE 3.3 Identification of REG2 binding to EXTL3 
(A) WT islets were treated with 1 g REG2-FITC or 1 g REG2-FITC + 5 g REG2 for 15 hours. 
Untreated islets served as a negative control. REG2 binding on the islet surface was visualized by 
fluorescent microscopy. (B) Design of pAPtag-5 vector encoding mouse Reg2 or Reg3 gene. The 
pAPtag-5 vector encoding mouse Reg2 was created by inserting the entire coding region of the gene 
between XhoI and XbaI, or Hind III and Bgl II. The vector encoding mouse Reg3  was created by 
inserting the gene between XhoI and XbaI. (C) Confirmation of AP protein expression and (D) REG2 
protein expression in the AP conditioned mediums by using the immunoblotting assay. (E) -TC3 cells 
transfected with EXTL3 or vector control (pcDNA3.1) were incubated with conditioned medium 
containing 200 nM pAP5, AP-REG3, AP-REG2 or REG2-AP protein. Binding was visualized with AP 
substrate BCIP/NBT. (n=4 to 5 per group). 
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positive binding with EXTL3, as the cells presented the same light colored background as the 
negative controls, and no dark purple areas are observed on these cells (Fig. 3.3E). Next, to look 
for proteins that preferentially interact with REG2 protein, we performed immunoprecipitation 
by using REG2 antibody. After pulling down endogenous REG2 and its binding partners from 
WT pancreas (Fig. 3.4A) or islets (Fig. 3.4B), the protein bands were excised from the gel and 
analyzed by mass spectrometry. We selected the candidates based on their top hits from the mass 
spectrometry and their involvement in actin cytoskeleton pathway or Ca
2+
 pathway, as these 
pathways are important for GSIS in islet  cells (Draznin, 1988; Wang and Thurmond, 2009). 
Among the top candidates, there are three plasma membrane proteins: epidermal growth factor 
receptor (EGFR), integrin beta 1 (ITG1), integrin alpha 5 (ITG5), and eight cytosolic proteins: 
valosin-containing protein (VCP), protein kinase C (PKC), phosphatidylinositol 3-kinase, 
regulatory subunit, polypeptide 1 isoform 2 (PI3K), NCK-associated protein 1 (NCKAP1), 
Cysteinyl-tRNA synthetase (CARS), Gelsolin (GSN), Heterogeneous nuclear ribonucleoprotein 
U (HNRNPU) and Sec23 homolog B (SEC23B). To confirm their one-to-one interaction with 
REG2, we used the AP-TAG binding assay to investigate the direct ligand-receptor binding of 
AP-REG2 or REG2-AP and the three membrane proteins on the cell surface. We also took 
advantage of the large-screen approach, yeast two hybrid, to confirm the interaction between 
REG2, REG2 N-terminal (Ntrl), REG2 C-type lectin domain (Clect), or REG2 C-terminal (Ctrl) 
and the eight cytosolic proteins. We have not yet been able to confirm the direct binding by 
using either the AP-TAG binding assay (Fig. 3.4C) or yeast-two-hybrid method (Fig. 3.4D, E). 
Alternative methods will be needed to confirm the direct interaction.  
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FIGURE 3.4 Identification of the unknown REG2 binding proteins 
(A, B) Immunoprecipitation (IP) was carried out using anti-REG2 antibody mixed with protein G beads 
and the whole cell lysate from WT pancreas or islets. Cell lysate with protein G beads or anti-REG2 
antibody with protein G beads served as negative controls. After washing, the eluted samples were loaded 
into SDS-PAGE gel and the gels were stained with Sypro Ruby dye. Extra bands from IP lane were cut 
for mass spectrometry analysis to identify potential REG2 binding proteins. (C) -TC3 cells transfected 
with EGFR, ITG1, ITG5 or vector control (pcDNA3.1) were incubated with conditioned medium 
containing 200nM pAP5, AP-REG2 or REG2-AP. Binding was visualized with AP substrate BCIP/NBT. 
(D) Purified PCR products for yeast two hybrid, including BD genes: Reg2, Ntrl, Clect, Ctrl; AD genes: 
Cars, Gsn, HnrnpU, Vcp, Pkc, Pi3k, Nckap1, Sec23b. (E) Vector design for yeast two hybrid: pBD-GAL4 
Cam and pAD-GAL4-2.1. 
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3.5 Discussion 
Despite several studies linking REG2 to diabetes, little is known about the REG2 function in 
insulin secretion and the underlying signaling pathway(s). Here, we report for the first time on 
how REG2 inhibited GSIS in the islets overexpressing GPX1 and the possible functional 
domains of REG2 protein that are involved in this role.  
 
We first confirmed the inhibitory role of REG2 on GSIS in OE islets under in vitro conditions 
using both static and perifusion systems. After verifying that KCl- and arginine-induced insulin 
release were not affected by REG2 treatment, we focused on the glucose metabolism pathway, 
which might explain an underlying signaling of REG2. The first key players involved in glucose 
metabolism are the glucose sensor system (GLUT2 and GK) that controls glucose uptake and 
initiates the glycolysis pathway (Meglasson and Matschinsky, 1984; Thorens and Mueckler, 
2010). Several studies have implied the regulation of REG2 on GLUT2. Liu and colleagues 
demonstrated that REG2 protects murine islet -cells from STZ-induced apoptosis (Liu et al., 
2010), and Xiong et al. showed the possible inhibitory effects of Reg3 on GLUT2 level to block 
STZ from entering islet -cells and protecting them from STZ-induced apoptosis (Xiong et al., 
2011). To understand the underlying mechanism behind how REG2 suppressed GSIS, we treated 
OE islets with REG2 and examined the mRNA and protein change of the key regulators. We 
observed time-dependent inhibition of Glut2, Gk1, Pklr, Cav1.2, Cav1.3 and Prkcb gene 
expression (P  0.05) after REG2 treatment (Fig. 3.2A, B, C, F, G, H). But we did not find any 
change of Ins1 and the transcription factors involved in insulin synthesis after REG2 treatment 
(Fig. 3.2I, J, K, L). We further examined the protein change of the key GSIS regulators. We 
showed REG2 treatment decreased GK activity (Fig. 3.2M), and GLUT2 protein level (Fig. 
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3.2O) in OE islets in comparison to their own control group, but we did not observe any change 
of PDX1 protein expression (Fig. 3.2O).  
 
Glycolysis in the  cell is tightly coupled to mitochondrial oxidative metabolism and 
mitochondrial membrane potential (Lowell and Shulman, 2005). One of the key regulators of 
GSIS is mitochondrial UCP2, which contributes to the proton leak in the mitochondria inner 
membrane, thus altering mitochondrial membrane potential and inversely correlated with GSIS 
(Krauss et al., 2002). Previously, we observed higher mitochondrial membrane potential and 
lower UCP2 protein level in OE islets as compared to the WT (Wang et al., 2008). To determine 
whether the mitochondria metabolism was affected by REG2, we measured the related gene and 
protein expression, as well as the mitochondria membrane potential change in REG2 pretreated 
OE islets. Although we didn’t see any gene change of Ucp2 (Fig. 3.2E), we found that the UCP2 
protein level was significantly up-regulated (Fig. 3.2O) by 1 g/ml REG2 treatment. UCP2 is an 
unstable protein with a very short half-life (Rousset et al., 2007). The protein level was decreased 
to 50% 25 minutes after treatment of cycloheximide in vitro and 60 minutes after injection of the 
translation inhibitor in mice (Rousset et al., 2007). Both mRNA and protein expression of UCP2 
were dependent on glucose metabolism, especially GK in pancreatic islets (Dalgaard, 2012) and 
the expression could be also up-regulated by mitochondria ·O2
-
 (Krauss et al., 2003). These 
characteristics of UCP2 indicate that REG2 might affect UCP2 protein stability in a glucose-
dependent way. Atp5b gene expression (Fig. 3.2D) and mitochondria membrane potential were 
also decreased (Fig. 3.2N) by REG2 treatment, implying decreased ATP production and 
decreased insulin secretion. 
83 
 
Overall, REG2 suppressed insulin secretion in a glucose-dependent manner. The REG2 
treatment of OE islets caused time-dependent suppression of genes involved in glucose and 
mitochondria metabolism, L-type voltage Ca
2+
 channels and Prkcb. Furthermore, REG2 also 
decreased the protein level of GLUT2, GK activity, and mitochondria membrane potential, and 
also increased UCP2 protein level in OE islets. However, it did not change either mRNA level of 
Ins1 or mRNA and protein expression of the transcription factors that regulate insulin 
biosynthesis. These results implied that REG2 regulated insulin level mainly through insulin 
secretion by glucose stimulation rather than insulin synthesis. 
 
We then asked which domains in the REG2 protein are responsible for the inhibitory role of 
GSIS. The REG family of genes belongs to the Ca
2+
-dependent lectin (C-type lectin) gene 
superfamily (Lasserre et al., 1994). The CTLD in REG proteins has antibacterial function 
(Lehotzky et al., 2010; Mukherjee et al., 2009; Mukherjee et al., 2013). This domain is involved 
in carbohydrate binding (Cash et al., 2006; Christa et al., 1994; Ho et al., 2010; Lehotzky et al., 
2010), through which the REG lectins can recognize their bacterial targets and mediate the 
function of killing and phagocytosis. Although there has not been any evidence of CTLD 
involvement in REG2 function, this domain might play an important role in GSIS suppression. 
Based on the carbohydrate- and calcium-binding sites in CTLD, G142, K157, and D158 in 
REG2 were predicted as the ligand-binding sites (Walker et al., 2004) (Fig. 3.5). To test whether 
or not the three residues are involved in REG2 function, we made REG2 M1 mutant with the 
three amino acid residues mutated to alanines (Fig. 3.1F). Interestingly, with the mutation in 
CTLD, the REG2 protein treatment of OE islets did not show significant inhibitory effects on 
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GSIS. This implied that mutation in the CTLD led to the loss-of-function of REG2 protein in 
inhibiting GSIS. In other words, CTLD might serve as the functional domain of REG2 protein.  
 
 
 
 
FIGURE 3.5 Predicted ligand binding surface in REG2 sequence The three amino acid residues, 
G142, K157, and D158, of REG2 predicted to be involved in ligand binding are shown. CD-Search was 
used to search the Conserved Domain Database with the REG2 amino acid sequence (Marchler-Bauer et 
al., 2009; Marchler-Bauer and Bryant, 2004).  
 
 
Human Reg1alpha (hReg1) was first discovered in pancreatic calcified stone (De Caro et al., 
1979), and was found to inhibit CaCO3 precipitation and prevent stone formation from pancreatic 
juice (Bernard et al., 1992; Giorgi et al., 1989; Iovanna et al., 1993; Multigner et al., 1983). The 
mouse Reg family protein models are shown in comparison to the hReg1 (Fig. 3.6), which has 
its structure determined. The acidic residues (Fig 3.6) of hReg1 were later shown to be 
involved in CaCO3 binding (Bertrand et al., 1996) and in the control of CaCO3 crystal growth 
(Sarles et al., 1990). Among the seven mouse Reg family proteins, the Reg1 and Reg2 models 
showed the greatest conservation of these acidic residues (Fig. 3.6). Based on the computational 
modeling prediction, as well as the involvement of calcium in insulin secretion, we hypothesized 
that the acidic residues (E59, D60, E66, D158, E159, E162) contributed to REG2 involvement in 
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the alteration of insulin secretion. To test this hypothesis, we mutated the six residues to glycine 
and treated OE islets with the purified recombinant REG2 M2 protein to study the change of 
insulin secretion. Similar to the native REG2 protein, REG2 M2 protein treatment suppressed 
insulin secretion in OE islets in a glucose-dependent manner. This finding shows that mutation 
of the acidic residues does not change the function REG2 protein on insulin secretion, indicating 
that these residues are not the functional domain of REG2 protein.  
 
The Reg family is a group of secretory proteins (Bacon et al., 2012; Carrère et al., 1999; Keel et 
al., 2009; Orelle et al., 1992; Zenilman et al., 2000) that were found to interact with their 
receptor, EXTL3, at the plasma membrane of the cells (Acquatella-Tran Van Ba et al., 2012; 
Kobayashi et al., 2000; Lai et al., 2012; Marchal et al., 2012). However, no studies have been 
shown on any REG2 interacting proteins. Thus we set out to identify the unknown binding 
partners. Because REG2 is a secreted soluble protein, the possibility of hormone-receptor 
interactions was considered. We firstly used the FITC-labeled REG2 protein to study the general 
REG2 binding on the cell surface. As expected, we observed significant increase of green 
fluorescence in the REG2-FITC-treated islets when compared with the control (Fig. 3.3A), as 
well as the islets treated with the mixture of FITC labeled/unlabeled REG2 (Fig. 3.3A). These 
results suggest a competitive binding of REG2 to its potential membrane target, thus implying 
that REG2 interacts with certain membrane protein on the cell surface. Since rReg1, hReg1, 
and hReg3 were shown to interact with EXTL3 and regulate cell function through EXTL3 
(Acquatella-Tran Van Ba et al., 2012; Kobayashi et al., 2000; Lai et al., 2012; Marchal et al., 
2012), it is logical to determine whether or not REG2 also binds to EXTL3.Thus far we were  
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FIGURE 3.6 Predicted acidic residues of REG proteins possibly involved in CaCO3 crystal binding.  
The mouse REG family protein models are shown in comparison to the human REG1, which has had its 
structure determined (top left).  The acidic residues (red) of hReg1 are involved in CaCO3 binding (all 
other residues are white) (Bertrand et al., 1996).  Among the mouse REG family proteins, the REG1 and 
REG2 models show the greatest conservation of these acidic residues. 
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unable to detect any interaction between these two proteins, as the EXTL3 overexpressing -TC3 
cells did not show positive binding to either AP-REG2 or REG2-AP (Fig. 3.3E). 
 
To continue looking for the REG2 receptor candidates, we used REG2 antibody to 
immunoprecipitate the potential REG2 binding proteins, and selected three precipitated proteins: 
EGFR, ITG1 and ITG5 based on the mass spectrometry results (Fig. 3.4A, B). EGFR is 
related to Reg family proteins. Although Bishnupuri group did not find a direct binding of EGFR 
and REG4, they found that EGFR mediated REG4-activated AKT-PI3K-AP1 signaling pathway 
in colon adenocarcinomas (Bishnupuri et al., 2006). There is also a strong correlation between 
EGFR and glucose metabolism mediated by glucose transporters. EGFR maintains basal 
intracellular glucose level by interacting and stabilizing sodium/glucose cotransporter 1 (SGLT1) 
to allow enough glucose uptake for ATP generation in cancer cells, and this is independent of its 
kinase activity (Weihua et al., 2008). EGFR also mediates EGF-induced alterations of glucose 
uptake and GLUT2 expression in hepatocytes (Lee et al., 2006) and SGLT1 expression in 
enterocytes (Chung et al., 1999). In addition, EGFR is transactivated by beta cellulin to enhance 
cell proliferation in islet  cells (Buteau et al., 2003), which demonstrated the involvement of 
EGFR in islet  cell function. Integrin receptors are a large family of proteins well-known for 
cell attachment with other cells or extracellular matrix (ECM). Integrins are heterodimeric 
transmembrane adhesion proteins composed of - and -subunits, which are critical for normal 
islet proliferation, differentiation and endocrine function (Bosco et al., 2000; Diaferia et al., 
2013; Jiang et al., 1999; Parnaud et al., 2006; Saleem et al., 2009). Integrin 1 has been 
established as a positive regulator of glucose metabolism (Riopel et al., 2011) and insulin 
secretion (Parnaud et al., 2006; Rondas et al., 2012) in islet  cells. Integrin 5, one of the seven 
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 subunits associated with Integrin 1 (Krishnamurthy et al., 2008), is involved in islet  cell 
function as well (Wang et al., 2005). Likewise, integrins are also involved in Reg signal 
transduction as pancreatic REG2 protein expression was reported significantly decreased in 
integrin 1-deficient mice (Riopel et al., 2013) and REG3 was found to decrease the 
dependence of adhesion on integrins in melanoma cells (Valery et al., 2001). Because we 
showed that REG2 inhibited glucose metabolism and insulin secretion and immune-precipitate 
REG2, EGFR, Integrin 1 and integrin 5 with endogenous REG2 protein, it is logical to 
speculate that at least one of them is the REG2 receptor. Unfortunately, we have so far not been 
able to detect a physical interaction between REG2 and either one of these receptor candidates. 
Alternative methods might be needed to continue further investigation.  
 
Taken together, these findings provided us with a mechanistic picture of how REG2 decreased 
glucose-stimulated insulin secretion in OE islets. Novel to this study is the discovery of the 
inhibitory role of REG2 in glucose-dependent insulin secretion OE islets in vitro, the 
downstream signaling pathway of REG2, as well as the domains that might confer the regulatory 
role in REG2 signaling on GSIS. 
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CHAPTER 4 
Dietary Se Deficiency Partially Rescues Type 2 Diabetes-Like Phenotypes of 
Glutathione Peroxidase-1-Overexpressing Male Mice 
 
4.1 Abstract 
This study was conducted to determine if dietary Se deficiency precluded GPX1 overproduction 
in OE mice and rescued their T2DM-like phenotypes. A total of 20 male OE and wild-type (WT) 
mice were fed a Se-deficient (<0.02 mg/kg) diet or Se-supplemented (0.3 mg/kg as sodium 
selenite) diet from 1 to 5 months of age. Dietary Se deficiency eliminated or attenuated (P < 
0.05) genotype differences in concentrations of fasting blood glucose, plasma insulin, and(or) 
hepatic lipids, insulin sensitivity, and glucose-stimulated insulin secretion. Dietary Se deficiency 
decreased (P < 0.05) OE islet mRNA levels of two key transcriptional activators (Beta2 and 
Foxa2), and removed their differences from the WT in 6 genes (Beta2, Cfos, Foxa2, Pregluc, 
Gk1 and Sur1) related to insulin synthesis and secretion. Depletion of Se in the OE mice also 
down-regulated (P < 0.05) hepatic mRNA levels of two key rate-limiting enzymes for 
lipogenesis (Acc1) and glycolysis (Gk1), along with activities of hepatic glucokinase and muscle 
phosphoenolpyruvate carboxykinase. Dietary Se deficiency affected (P < 0.05) blood glucose, 
plasma insulin, insulin sensitivity, and hepatic lipid profiles in the WT mice as similarly in the 
OE mice. In conclusion, dietary Se deficiency precluded the GPX1 overproduction in the full-fed 
OE mice and partially rescued their metabolic syndromes. This alleviation resulted from 
mitigating expression and (or) function of pro-insulin genes, lipogenesis rate-limiting enzyme 
genes, and key glycolysis and gluconeogenesis enzymes in islets, liver, and muscle. 
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4.2 Introduction  
Se was considered to be anti-diabetic (Faure, 2003; Mueller and Pallauf, 2006) due to its insulin-
mimetic effect (Ezaki, 1990). Indeed, Se deficiency is associated with diabetes (Akbaraly et al., 
2010; Kljai and Runje, 2001; Navarro-Alarcon et al., 1999), and administration of Se to 
streptozotocin-induced diabetic rats restored their glycemic control (Battell et al., 1998; 
Chaturvedi et al., 1991). However, a number of recent human studies have shown a 
hyperglycemic, hyperlipidemic, and pro-diabetic effect of Se supplements (Bleys et al., 2007; 
Bleys et al., 2008; Stranges et al., 2010b). Our laboratory demonstrated that a prolonged feeding 
of high dietary Se (3 mg/kg) induced mild gestational diabetes in the first-parity pregnant rats 
and insulin resistance in their offspring (Zeng et al., 2012). While other groups have also shown 
similar (Labunskyy et al., 2011) effects of Se on body glucose and lipid metabolism, 
mechanisms and health impacts of such effects of Se remain unclear or controversial.   
 
GPX1 was the first-identified selenoprotein in mammals (Rotruck et al., 1973) and has been 
widely considered to be a major antioxidant intracellular enzyme (Lewis et al., 2007). While 
GPX1 activity is extremely low in islets (Grankvist et al., 1981; Lenzen et al., 1996) and is 
altered in development of diabetes (Peuchant et al., 2004) and complications (Hamanishi et al., 
2004; Kuzuya et al., 2008; Lewis et al., 2007; Nemoto et al., 2007), an increased activity of this 
enzyme in erythrocytes was actually associated with hyperinsulinemia and insulin resistance in 
pregnant women (Chen et al., 2003). More striking, our laboratory found that overexpression of 
GPX1 in mice induced hyperglycemia, hyperinsulinemia, insulin resistance, and obesity at 6 
months of age (McClung et al., 2004). To rescue these phenotypes and reveal the underlying 
mechanisms, we first employed diet restriction on the OE mice from 2 to 6 months of age (Wang 
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et al., 2008). Because this extended diet restriction eliminated all these type 2 diabetes-like 
phenotypes except for fasting hyperinsulinemia and hyper-secretion of insulin by glucose 
stimulation, these two abnormalities seemed to be the primary effect of GPX1 overproduction. 
To further eliminate these two phenotypes for a full rescue of these mice, we conducted a second 
experiment and employed dietary Se deficiency on the feed-restricted OE mice to preclude their 
GPX1 overproduction (Pepper et al., 2011). However, the dietary Se depletion showed no 
additional benefit, above that of the diet restriction alone, to the OE phenotypes. As metabolic 
impacts of the latter might be too drastic to allow demonstrations of the former effects on the OE 
phenotypes, such impacts of GPX1 activity exclusion should be tested in the full-fed OE mice. 
 
Synthesis and secretion of insulin in pancreatic islets are regulated by transcriptional factors, 
signal molecules, and functional proteins encoded by genes such as Pdx1, Beta2, hnf1 homeobox 
a (Hnf1a), Foxa2, v-maf musculoaponeurotic fibrosarcoma oncogene family protein a (Mafa), 
Glut2, and Gk1(Ahlgren et al., 1998; Gu et al., 2010; Lantz et al., 2004; Shih et al., 2001; 
Thorens et al., 1990; Winzell et al., 2011; Zhao et al., 2005). Hepatic lipogenesis is controlled by 
regulatory proteins and functional enzymes encoded by genes such as sterol regulatory element 
binding transcription factor 1a (Srebp1a), sterol regulatory element binding factor 2 (Srebp2), 
acetyl-coenzyme A carboxylase 1 (Acc1), fatty acid synthase (Fasn), and peroxisome 
proliferator-activated receptor gamma (Pparγ) (Jones et al., 2005; Mao et al., 2006; Paulauskis 
and Sul, 1988; Shimano, 2002). GK plays a key role in glucose oxidation (glycolysis), and 
phosphoenolpyruvate carboxykinase (PEPCK) is the rate-limiting enzyme in gluconeogenesis 
(Granner and Pilkis, 1990). As a major signal protein of cell death/survival, p53 is also involved 
in carbohydrate and lipid metabolism (Ashur-Fabian et al., 2010; Yahagi et al., 2004). We have 
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previously demonstrated distinct impacts of GPX1 knockout or overexpression on expression 
and function of many of these factors (Wang et al., 2011b; Wang et al., 2008). Plausibly, 
disorders of glucose and lipid metabolism in the OE mice might result from dys-regulations of 
those factors by the overproduction of GPX1. Therefore, our objective was to determine: 1) if a 
prolonged dietary Se depletion in the OE mice rescued their type 2 diabetes-like phenotypes; 2) 
if the presumed rescue was mediated by modulating expression and function of key factors 
related to insulin synthesis, secretion, and function in islets and lipogenesis, glycolysis, and 
gluconeogenesis in liver and muscle.         
 
4.3 Materials and Methods  
Mice, Diets, Physiological Tests, and Tissue Sample Collections 
Our mouse experiments were approved by the Institutional Animal Care and Use Committee at 
Cornell University. Mice were reared in plastic cages in an animal room with constant 
temperature (22°C) and a 12 h light:dark cycle, and were given free access to feed and distilled 
water. The OE mice were derived from a B6C3 (C57B1×C3H) hybrid line (Taconic,
 
Germantown, NY, USA) (Cheng et al., 1997). A total of 20 weanling male (1-month old) WT 
and OE mice (n = 5 for each genotype by diet) were fed a Torula yeast and sucrose based diet 
(TABLE B.) (Cheng et al., 1997) with Se-deficient (< 0.02 mg Se/kg, WT- and OE-) or Se-
adequate (0.3 mg Se/kg as sodium selenite, WT+ and OE+) for 4 months, respectively. Mice 
were fasted 8 h overnight before all measures or experiments. Individual body weights, blood 
glucose concentrations, plasma insulin concentrations, insulin and glucose tolerances (ITT, 0.5 U 
insulin/kg body weight and GTT, 1g dextrose/kg), and glucose-stimulated insulin secretion 
(GSIS, 1 g dextrose/kg) of mice were recorded or determined at initial and then monthly. Blood 
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samples were collected via tail bleeding, blood glucose was determined by using a glucometer 
(Bayer, Elkhart, IN), and plasma insulin was determined by using a rat/mouse insulin ELISA kit 
(Crystal Chem, Downers Grove, IL). At the end of study, all experimental mice were killed to 
collect blood (heart), pancreatic islets, liver, and muscle that were stored at -80
0
C before 
analysis. The pancreatic islets were isolated and handpicked from mice using a standard 
procedure with minor modifications (Wang et al., 2008). 
 
Molecular and Biochemical Assays 
Total RNA was isolated from liver and pancreatic islets using a Trizol kit (Invitrogen, Carlsbad, 
CA) and the subsequent analysis by quantitative real-time PCR (Q-PCR) of 21 insulin synthesis 
and secretion-related genes in islets and 10 lipogenesis-related genes in liver were carried out as 
previously-described (German, 1993; Pepper et al., 2011).  Each reaction was run in triplicate 
with validated primers listed in TABLE C. Liver lipid was extracted using a 
chloroform:methanol method and concentrations of TG, total cholesterol (TC), and non-
esterified fatty acid (NEFA) were measured using commercial kits (Wako Chemicals, Richmond, 
VA). Hepatic GPX1 activity was measured at 25
o
C using the coupled assay of NADPH 
oxidation as previously described (Lei et al., 1995). Hepatic GK activity was measured in a 
reaction coupled with glucose-6-phosphate dehydrogenase through monitoring production of 
NADPH (Danial et al., 2003). Liver and muscle PEPCK activities were determined using a 
spectrophotometric assay (Duff and Snell, 1982). Immunoblotting analysis of hepatic p53 protein 
was performed as described (Cheng et al., 1999a) using a primary rabbit antibody against mouse 
p53 protein (Cell Signaling, Danvers, MA), and relative density of the protein bands was 
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quantified using Canvas 7 software (Deneba Systems, Miami, FL). Protein concentration was 
determined using a BCA protein assay kit (Thermo Scientific, Rockford, IL). 
 
Statistical Analysis  
Data were analyzed using SAS (release 6.11; SAS Institute, Cary, NC, USA). Dietary Se and 
genotype effects were tested by two-way ANOVA with (body weight and physiological data) or 
without (gene, protein, lipid, and enzyme data) time-repeated measurements. Data are presented 
as mean ± SE and significance was set at P  0.05. 
 
4.4 Results 
4.4.1 Dietary Se Deficiency on Mouse Metabolic Phenotypes. 
The OE mice had higher (P < 0.05) hepatic GPX1 activity than the WT mice, whereas dietary Se 
deficiency decreased (P < 0.05) the activity in both genotypes (Fig. 4.1A). The final body weight 
of OE mice was 27% heavier (P < 0.05) than the WT mice (Fig. 4.1B), and this genotype 
difference (P < 0.05) appeared as early as the first month (data not shown). However, dietary Se 
deficiency did not produce any or statistically-significant effect on mouse body weight at any 
time-point. In contrast, dietary Se deficiency decreased (P < 0.05) fasting blood glucose 
concentrations in both OE and WT mice and minimized their genotype difference at the final 
month (Fig. 4.1C). Dietary Se deficiency decreased (P < 0.05) post-mortem fasting plasma 
insulin concentration (Fig. 4.1D), and improved (P < 0.05) blood glucose tolerance or clearance 
in the OE mice (Fig. 4.2A). However, dietary Se deficiency impaired the early phase (15 and 30 
min) of blood glucose clearance in the WT mice (Fig. 4.2A).  
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FIGURE 4.1 Effects of dietary Se concentration [deficiency as (-) and adequacy as (+)] on GPX1 
activity, body weight, blood glucose and plasma insulin level.  
(A) Hepatic GPX1 activity, (B) Body weight, (C) Fasting blood glucose concentration, and (D) Post-
mortem fasting plasma insulin concentration in WT and OE mice at the end of experiment (5 months of 
age). Data presented as mean ± SE (n = 3 to 4 for panels A and D, n = 5 to 10 for panels B and C). Means 
for a given measure without sharing a common letter differ (P < 0.05).  
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FIGURE 4.2 Effects of dietary Se concentration [deficiency as (-) and adequacy as (+)] on glucose 
tolerance, insulin tolerance and insulin secretion.  
(A) Body glucose tolerance (GTT, 1 g glucose/kg), (B) Body insulin tolerance (ITT, 0.5 U insulin/kg), 
(C) Glucose-stimulated insulin secretion (GSIS, 1g dextrose/kg) in WT and OE mice at 1 wk prior to the 
end of experiment. Data presented as mean ± SE (n = 5). Means for a given measure at a given time-point 
without sharing a common letter differ (P < 0.05).  
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Dietary Se deficiency improved (P < 0.05) insulin sensitivity at various time-points in both 
genotypes, and the magnitude of improvement was greater in the OE than the WT mice (Fig. 
4.2B). Impacts of dietary Se and genotypes on the relative changes of body insulin and glucose 
tolerances were presented in Supplemental Fig. 1. Dietary Se deficiency attenuated (P < 0.05) 
plasma insulin concentrations at 0, 15, and 30 min after GSIS by 37, 42 and 45%, respectively, in 
the OE mice, but showed little effect in the WT mice (Fig. 4.2C). In Se adequacy, hepatic 
concentrations of TG, TC and NEFA (Fig. 4.3A, B, C) were 31, 105, and 37% greater (P < 0.05) 
in the OE than the WT mice, respectively. However, these genotype differences were either 
minimized or eliminated by dietary Se deficiency.  
 
4.4.2 Dietary Se Deficiency on Islet Gene Expression. 
Among the assayed genes in islets, 16 of them were affected (P < 0.05) by dietary Se and (or) 
genotype. Compared with their Se-adequate OE islets, the Se-deficient OE islets showed lower 
(P < 0.05) OE islet mRNA levels of Beta2 and Foxa2 and a decline trend (P < 0.09) of Cfos and 
Pregluc, but elevated (P < 0.05) mRNA levels of Hnf1a, Hnf4, Kir6.2 and Cat (Fig. 4.4A). In 
the WT islets, dietary Se deficiency enhanced (P < 0.05) mRNA levels of Cfos, Hnf4, Foxo1, 
Gk1, Ins1, and p53 (Fig. 4.4A, B). Genotype differences between the Se-adequate WT and OE in 
islet mRNA levels of 6 genes (Beta2, Cfos, Foxa2, Pregluc, Gk1 and Sur1) were removed by 
dietary Se deficiency (Fig. 4.4A, B). Neither genotype nor dietary Se showed significant effect 
on islet mRNA levels of Irs2, Jund, Mafa, Sirt1, or Ucp2 (Supplemental Fig. 2).  
 
4.4.3 Dietary Se Deficiency on hepatic Lipogenesis Gene Expression.  
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FIGURE 4.3 Effects of dietary Se concentration [deficiency as (-) and adequacy as (+)] on hepatic 
lipid profiles. Hepatic concentrations of (A) TG, (B) TC, and (C) NEFA in WT and OE mice at the end 
of experiment (5 months of age). Data presented as mean ± SE (n = 5). Means for a given measure 
without sharing a common letter differ (P < 0.05).   
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FIGURE 4.4 Effects of dietary Se concentration [deficiency as (-) and adequacy as (+)] on 
pancreatic islet mRNA abundances of insulin-related genes in WT and OE mice at the end of 
experiment (5 months of age). Panel A shows genes in the OE islets that were responsive to dietary Se 
deficiency, whereas panel B shows those less responsive to the same treatment. Data presented as mean ± 
SE (n = 5). Means for a given gene without sharing a common letter differ (P < 0.05).  
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Hepatic Gk1 mRNA abundance was 62-fold greater (P < 0.01) in the Se-adequate OE than the 
Se-adequate WT mice, while dietary Se deficiency produced (P < 0.05) opposite changes of the 
Gk1 expression between the two genotypes (Fig. 4.5). Meanwhile, dietary Se deficiency 
increased (P < 0.05) Pparγ in the OE mice, but decreased (P < 0.05) Srebp1a and Srebp2 in the 
WT mice and Acc1 in the OE mice (Fig. 4.5). In addition, the OE mice displayed greater (P < 
0.05) mRNA levels of Acc1, Cyp7a1, Fasn, Mccc1, and Pparγ, but lower (P < 0.05) mRNA 
levels of F1,6bp and Hmgcs2 than the WT mice (Fig. 4.5).  
 
4.4.4 Dietary Se Deficiency on Tissue GK and PEPCK Activities and p53 Protein.  
Hepatic GK activity in the Se-adequate OE mice was 2.5-fold greater (P < 0.05) than that of the 
Se-adequate WT mice (Fig. 4.6A). Dietary Se deficiency suppressed (P < 0.05) the enzyme 
activity in the OE mice to the level similar to that of the WT mice. Likewise, muscle PEPCK 
activity was 6-fold (P < 0.05) greater in the Se-adequate OE mice than in the Se-adequate WT 
mice (Fig. 4.6B), and dietary Se deficiency decreased (P < 0.05) the enzyme activity by 38% in 
the OE mice. Hepatic PEPCK activity was decreased (P < 0.05) by dietary Se deficiency in the 
WT. Liver p53 protein in the Se-deficient WT was 1.2-fold higher (P < 0.05) than that in the Se-
adequate WT (Fig. 4.6C).  
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FIGURE 4.5 Effects of dietary Se concentration [deficiency as (-) and adequacy as (+)] on hepatic 
mRNA abundances of lipogenesis-related genes in WT and OE mice at the end of experiment (5 
months of age). Data presented as mean ± SE (n = 5). Means for a given gene without sharing a common 
letter differ (P < 0.05).  
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FIGURE 4.6 Effects of dietary Se concentration [deficiency as (-) and adequacy as (+)] on glucose 
homeostasis-related enzyme activities and P53 protein level. (A) Hepatic GK activity, (B) Hepatic and 
muscular PEPCK activities, and (C) Hepatic P53 protein in WT and OE mice at the end of experiment (5 
months of age). Data presented as mean ± SE (n = 4 to 5) and the image (C) was a representative of 4 
independent experiment. Means for a given measure without sharing a common letter differ (P < 0.05).  
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4.5 Discussion  
The present study represents the third experiment out of a series of attempts to rescue the type 2 
diabetes-like phenotypes in the OE mice. After we obtained a partial rescue of these phenotypes 
by diet restriction (Wang et al., 2008) and no additional benefit of dietary Se deficiency in the 
diet-restricted OE mice (Pepper et al., 2011), this study was conducted to explore if dietary Se 
deficiency in the full-fed OE mice could completely rescue their phenotypes. While dietary Se 
deficiency indeed precluded the GPX1 overproduction in the OE mice and thus minimized their 
GPX1 activity difference from the WT mice, three of their phenotypes including hyperglycemia, 
insulin resistance, and elevated hepatic lipid profiles (McClung et al., 2004) were nearly rescued. 
Meanwhile, their hyperinsulinemia and aggravated GSIS were also improved by dietary Se 
deficiency. Interestingly, the overall impact of dietary Se deficiency in the full-fed OE mice 
resembled that by diet restriction in Se-adequate OE mice (Wang et al., 2008). Because these two 
treatments produced distinct primary effects, it is fascinating for us to see indistinct phenotype 
responses to them. Specifically, diet restriction in the Se-adequate OE mice eliminated obesity 
and brought their body weight down to a level lower than the WT mice, but had little effect on 
activities of GPX1 and other two selenoproteins in liver, pancreas, muscle, and plasma (Wang et 
al., 2008). In contrast, dietary Se deficiency in the full-fed OE mice in the present study 
decreased their liver GPX1 activity, but did not alter their body weight. Thus, diet restriction 
alleviated the OE phenotypes by mechanisms related to the obesity, whereas the actions of 
dietary Se deficiency were mediated by precluding the overproduction of GPX1 activity and 
perhaps down-regulation of other selenoproteins as well (Pepper et al., 2011; Wang et al., 2008). 
Intriguingly, these two treatments showed no additive benefit on the OE phenotype in our second 
experiment of the series (Pepper et al., 2011). In that case, diet restriction seemed to be too 
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drastic to allow a demonstration of metabolic impact of dietary Se deficiency. Furthermore, 
neither dietary Se deficiency from 1 to 5 months of age nor diet restriction from 2 to 6 months of 
age could completely rescue hyperinsulinemia or aggravated GSIS. Likely, these two disorders 
were pre-disposed by GPX1 overproduction in prenatal or neonatal stages. 
 
Two “pro-insulin” genes: Beta2 (Gu et al., 2010; Malecki et al., 1999) and Foxa2 (Lantz et al., 
2004), were decreased by dietary Se deficiency in the OE mice. Because these two genes encode 
key transcriptional factors for beta cell differentiation and insulin synthesis (Gu et al., 2010; Lee 
et al., 2002), down-regulations of their mRNA and presumably their functional protein levels in 
the OE mice were consistent with their hypoinsulinemic response to dietary Se depletion. 
Meanwhile, dietary Se deficiency also removed the genotype differences between the Se-
adequate WT and OE islets in another 4 genes (Cfos, Pregluc, Gk1, and Sur1) related to insulin 
synthesis and secretion. These changes offer potential mechanistic explanations to the attenuated 
hyperinsulinemia and improved GSIS in the Se-deficient OE mice. Physiological implications 
remain unclear to us for the elevated islet Hnf1a, Hnf4, and Kir6.2 mRNA levels by dietary Se 
deficiency in the OE mice. Up-regulation of these pro-insulin synthesis and secretion genes may 
be perceived as a feedback response to the improved metabolic condition and(or) down-
regulation of other pro-insulin genes. Among the 6 genes up-regulated by dietary Se deficiency 
in islets of the full-fed WT mice, 2 of them (Ins1and Gk1) were also enhanced by dietary Se 
deficiency in islets of the restricted-fed WT mice (Pepper et al., 2011). Thus, Ins1 and Gk1 are 
highly responsive to dietary Se supply or body Se status.  
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The improved hepatic lipid profile in the Se-deficient OE mice, compared with their Se-adequate 
controls, was concurrent with a down-regulation of the GK mRNA level and activity. Being an 
insulin-dependent key factor involved in lipogenesis (Foretz et al., 1999), GK activity is closely 
related to energy production through glycolysis and reactions in tricarboxylic acid cycle 
(Matschinsky, 1996), and consequently provides substrate precursors such as acetyl-CoA and 
NADPH for biosynthesis of cholesterol and other lipids. In Se adequacy, hepatic GK mRNA 
level and activity were over 62- and 2.5-fold greater in the OE than the WT mice, respectively. 
Clearly, the suppression of hepatic GK activity by dietary Se deficiency in the OE mice to the 
level of WT mice helped down-regulate that pathway of lipogenesis. Meanwhile, down-
regulation of hepatic Acc1 in the Se-deficient OE mice was also attributed to their decreased 
hepatic lipid profiles because ACC1 is a rate-limiting enzyme of lipogenesis that is activated by 
insulin (Scott et al., 2012). The elevated hepatic Pparγ expression in the Se-deficient OE mice 
was hard to link to their hepatic lipid status, but the decreased muscle PEPCK activity was 
consistent with the hypoglycemic response to dietary Se deficiency, presumably by decreasing 
gluconeogenesis (Yang et al., 2009). Meanwhile, the hypoglycemic and lowering hepatic lipid 
profile effect of dietary Se deficiency in the WT mice was associated with a down-regulation of 
GK and PEPCK activities and an up-regulation of p53 protein in liver. While key roles of GK in 
glycolysis and PEPCK in gluconeogenesis are well-documented (Granner and Pilkis, 1990), the 
tumor suppressor p53 protein has been revealed recently as a novel regulator of lipid metabolism 
pathways that is involved in the development of obesity and fatty liver diseases (Ashur-Fabian et 
al., 2010; Yahagi et al., 2004). Long-term dietary selenomethionine consumption has been 
shown to increase exon-specific DNA methylation of p53 gene in a Se-dose-dependent manner 
in rat liver (Zeng et al., 2011). Thus, the elevated hepatic p53 protein in the Se-deficient WT 
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mice not only helps explain the attenuated lipogenesis, but also unveils a novel link between 
Se/GPX1 and p53 on glucose and lipid metabolism. In addition, an increased hepatic Gk1 mRNA 
in the Se-deficient WT mice might be perceived as a feedback mechanism in response to the 
declined GK activity (Jackson et al., 2000). Meanwhile, down-regulation of hepatic Srebp1a and 
Srebp2 mRNA in the Se-deficient WT mice was also supposed to inhibit lipogenesis because 
these two genes encode key transcriptional factors of lipogenesis (Edwards et al., 2000). 
 
In summary, dietary Se deficiency partially disallowed the GPX1 overproduction in the full-fed 
OE mice and nearly rescued all of their type 2 diabetes-like phenotypes. As proposed in Fig. 4.7, 
the observed improvement was associated with down-regulations of “pro-insulin synthesis and 
secretion” genes in islets, lipogenesis rate-limiting enzyme genes in liver, and key glycolysis and 
gluconeogenesis enzymes in liver and(or) muscle. Although molecular or physical implications 
for certain changes of these assayed genes remain elusive, our study have demonstrated a strong 
regulation of the hepatic GK mRNA and activity by GPX1 overproduction and dietary Se 
deficiency, and a novel link of Se/GPX1 to p53 on body energy metabolism. Despite the focus 
on GPX1 role in the OE phenotype in the present study, other Se-dependent proteins including 
selenoprotein P (Misu et al., 2010; Speckmann et al., 2008), methionine-R-sulfoxide reductase 
B1 (Labunskyy et al., 2011), thioredoxin reductase 3 (Labunskyy et al., 2011), and selenoprotein 
S (Gao et al., 2004) have also been shown to be involved in glucose metabolism or diabetes. 
Because expressions of these proteins are affected by dietary Se (Labunskyy et al., 2011; Zeng et 
al., 2012), and to a certain extent by the GPX1 overproduction (Labunskyy et al., 2011), our 
ongoing research is assessing their relative roles in the dietary Se-mediated changes of the OE 
phenotypes.   
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FIGURE 4.7 Scheme of the regulation of dietary Se deficiency on the T2DM-like phenotypes in OE 
mice.      
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CHAPTER 5 
General Discussion and Future Directions 
 
5.1 General Discussion 
OE mice have developed hyperinsulinemia, hyperglycemia, insulin resistance, and obesity 
(McClung et al., 2004), and their islets have exhibited diminished Reg2 gene expression (Fig. 
1.5A, B). The overall research objective for this dissertation is to understand how GPX1 
overexpression led to the T2DM-like phenotypes in mice, with the long-term goal of innovative 
drug development to treat T2DM in humans and to improve human life.  
 
In Chapter 2, studies were conducted to investigate whether or not the ROS and GSH are the 
mediator of downregulation of the REG2 protein by GPX1, and whether or not exogenous REG2 
administration in OE mice has any therapeutic effect on the OE T2DM-like phenotypes. To 
address these questions, we firstly examined REG2 protein change in the islet and pancreas after 
changing the ROS level in vitro and in vivo. We observed a down-regulated REG2 protein level 
in islets treated with antioxidants: ebselen, NAC or Na2SeO3, and observed up-regulated REG2 
protein expression in islets or pancreas that had increased oxidative stress after H2O2, STZ or DQ 
treatment. Next, we expressed and purified the recombinant mouse REG2 protein from yeast and 
i.p. injected it into OE mice to examine the potential therapeutic role of REG2. Strikingly, 
fifteen-minute pre-injection of REG2 protein decreased glucose tolerance and glucose-stimulate 
insulin secretion in OE mice. Two-week daily exogenous REG2 protein administration 
decreased fasting blood glucose, plasma insulin, GSIS, glucose tolerance, body weight, and 
plasma TG, but not insulin tolerance. Taken together, we demonstrated that GPX1 
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downregulated REG2 by modulating the redox state. The depletion of islet Reg2 by GPX1 
overexpression mediated some of the OE T2DM-like phenotypes, as injection of REG2 in OE 
mice alleviated hyperinsulinemia, hyperglycemia and hypertriglycemia.  
 
In Chapter 3, the research was mainly focused on studying the molecular mechanisms underlying 
how REG2 decreased insulin secretion in vitro. Firstly, we confirmed that REG2 inhibited 
insulin secretion in a glucose-dependent way, as GSIS was decreased by the REG2 pre-
treatment, but not the KCL-stimulated or arginine-stimulated insulin secretion. These results 
suggested that glucose metabolism-related pathways might be the main target for REG2 in the 
OE islets. To test this hypothesis, we examined the change of the key regulators in the pathway 
after REG2 treatment. As expected, we observed a decrease in glucose metabolism-related genes 
such as Glut2, Gk1, Pklr, Atp5b, Cav1.2, Cav1.3 and Prkcb, but not in insulin synthesis-related 
genes, such as Ins1, Foxa2, Beta2 and Pdx1. We also detected decreases in GLUT2 protein 
level, GK activity, and mitochondria membrane potential, as well as an increase in UCP2 protein 
level after REG2 treatment in OE islets. Secondly, we found that the ligand-binding residues in 
the CTLD might be the functional domain that enabled the REG2 protein to decrease GSIS in 
islets, and not the acidic residues that were predicted to bind to CaCO3. This conclusion was 
supported by the fact that REG2 with mutation in CTLD failed to suppress GSIS, while the 
REG2 with mutation in the acidic residues showed similar GSIS inhibition effects as the native 
REG2 protein. These findings strongly suggested that the depleted Reg2 in OE islets played an 
important role in development of T2DM-like phenotypes in OE mice. This study opens new 
doors to bridge two “unrelated” fields and expands the function of GPX1 as an antioxidant. In 
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addition, it provides new insights into a therapeutic strategy for T2DM, in particular the 
prediabetic state in human. 
 
In Chapter 4, the objective was to determine whether or not dietary Se deficiency could preclude 
GPX1 overproduction and rescue the T2DM-like phenotypes in full-fed OE mice. After a 4-
month feeding trial, OE mice fed a Se deficiency diet showed significant reduction of liver 
GPX1 activity, improved hyperinsulinemia, hyperglycemia, insulin sensitivity, and glucose 
tolerance when compared to the OE mice fed a Se adequate diet. These alleviated T2DM-like 
phenotypes could be explained by the decreased expression of “pro-insulin synthesis and 
secretion” genes in islets as well as decreased insulin synthesis and secretion level; 
downregulation of protein activity of the key enzymes that regulate glycolysis and 
gluconeogenesis and decreased blood glucose, such as GK and PEPCK.  
 
In summary, the major discoveries of this dissertation are as follows: 
1. New insights into the biochemical regulation of REG2 by GPX1. 
2. First-time identification of the downstream signaling pathway of REG2 and the possible 
functional domain of REG2 protein.   
3. Novel therapeutic potential of REG2 and dietary Se manipulation in treating T2DM, which 
may lead to innovative drug discovery. 
 
5.2 Future Directions 
Future studies will focus on identifying the REG2 putative receptor in islets and how it interacts 
and inhibits the glucose metabolism pathway to regulate GSIS. Although we have identified 
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some interacting protein candidates using immunoprecipitation and mass spectrometry, we have 
not been able to confirm the one-to-one direct binding by using either AP-TAG binding assay or 
yeast two hybrid approach. Different binding conditions may be used to test the binding of REG2 
and its interacting partners, such as changing the concentration of glucose or CaCl2 in the AP 
conditioned medium. Meanwhile, alternative approaches can be used, such as Co-
immunoprecipitation or Bimolecular fluorescence complementation.  
 
Although we did not identify calcium channel, voltage-dependent, L type, alpha 1C 
subunit (Cav1.2) from our IP-MS study, Cav1.2 can be another REG2 binding candidate based 
on its physiological function in insulin secretion and its binding capability to lectins. L-type 
voltage-gated calcium channel plays important roles in GSIS by activating Ca
2+
 influx upon 
membrane depolarization. One of the isoforms, Cav1.2 determines the main electrophysiological 
and pharmacological properties of the channel. Deletion of Cav1.2 in mice significantly reduces 
first phase insulin release (Schulla et al., 2003), while knockdown Cav1.2 in INS-1 832/13 cells 
impaired GSIS (Nitert et al., 2008). Regulation of Cav1.2 cluster trafficking to cell surface is one 
of the mechanisms that Cav1.2 regulate -cell Ca2+ homeostasis and GSIS (Buda et al., 2013). 
Cav1.2 was also found to interact with lectins (Wang et al., 2011a). Galectin-1 (Gal-1) is beta-
galactoside-binding lectin and a carbohydrate-binding protein that can inhibit Cav1.2 current via 
interacting with Cav1.2 and reducing the functional surface expression of Cav1.2 (Wang et al., 
2011a). The 1c I-II loop of Cav1.2 is involved in the binding of Gal-1. Since REG2 has a 
conserved C-type lectin domain, this domain may enable REG2 to interact with Cav1.2. To test 
the hypothesis, we can use the AP-TAG binding assay or Co-immunoprecipitation method to 
determine the physical interaction between REG2 and Cav1.2.  
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APPENDIX 1 
TABLE B.     Composition of Torula yeast basal diet 
 
Ingredient Percentage of diet 
Torula yeast
2
 40.00 
Sucrose
3
 52.20 
Stripped corn oil
3
 5.00 
DL-Methionine
3
 0.50 
Vitamin mix
4
 0.20 
Mineral mix
5
 2.10 
 
1. Diet is supplemented Se (Na2SeO3) at < 0.02 mg/kg or 0.3 mg/kg.  
2. Torula yeast was purchased from Rhinelander Paper Compnay, Inc., Lake States 
division (Rhinelander, WI), and contained less than 0.02 mg Se/kg by analysis.  
3. Sucrose, corn oil, and DL-methionine were purchased from Dyets Inc. (Bethlehem, 
PA).  
4. Vitamin mix components (per kg diet): all-trans retinyl palmitate, 10.0 mg; 
cholecalciferol, 45.0 μg; menadione sodium bisulfite, 1.2 mg; biotin, 0.2 mg; vitamin B-
12, 0.015 mg; d-calcium-pantothenate, 30.0 mg; folacin, 4.0 mg; niacin, 50.0 mg; 
pyridoxine HCl, 10.0 mg; riboflavin, 10.0 mg; and thiamine HCl, 10.0 mg. 
5. Mineral  mix components (per kg diet): CaCO3, 19.69g; NaCl, 1.2g; MnSO4,  60 mg;   
KCO3, 1.0 mg; MgSO4*7H2O, 6.15g; FeSO4*7H2O, 0.5h; ZnO, 0.1g; CuSO4*7H2O, 
20.0mg; CoCl2*6H2O, 3.34mg; NaMoO4*2H2O, 6.7mg;  and Ni(NO3)2*6H2O, 
15.0mg.   
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APPENDIX 2 
TABLE C.     Q-PCR Primers 
 
Gene 
Name 
For ( 5'---3' ) Rev ( 5'---3' ) 
ISLETS 
Atp5b CTGATAAGCTGGCAGAAGAGCA CTGAGCTCTCGCTTGATATGGA 
Beta2 GCCCAGCTTAATGCCATCTTT CAAAAGGGCTGCCTTCTGTAA 
Cat TCCAGTGCGCTGTAGATGTGAA TGTTCTCACACAGGCGTTTCCT 
Cav1.2 CACTGGAGCAAGGGTTCAATA GATGCTCAACCAAACTCGAAAG 
Cav1.3 GAAGCACCTTTGACAACTTTCC ATCACCGCATTCCAGTCTTC 
Cfos ATTTGACTGGAGGTCTGCCTG CACGTTGCTGATGCTCTTGAC 
Foxa2 TGCCCCCTACGCCAACATGA TGGCGTGTGTGTAGCTGCGT 
Foxo1 GCTGCAATGGCTATGGTAGGA GTCACAGTCCAAGCGCTCAAT 
Gk1 CTGTTAGCAGGATGGCAGCTT TTTCCTGGAGAGATGCTGTGG 
Glut2 CTCCAGGAAGGGTGCTAAACC TGCTCCCTATCCGTTCTTCAA 
Hnf1a GTGTAACTGCACAGGAGGCAAA TTCTCACGTGTCCCAAGACCTA 
H  GCCACAGTTTTCCACCAAGAG AAGGAGGACGTCTGCTTCTGA 
Hprt GGCCAGACTTTGTTGGATTTG TGCGCTCATCTTAGGCTTTGT 
Igf1 CAGGGATGAAGAAGGAGCAGA TAAGTGCCGTATCCCAGAGGA 
Ins1 AGGACCCACAAGTGGAACAAC GTGCAGCACTGATCCACAATG 
Irs2 GCCTGGGGATAATGGTGACTA TCCATGAGACTTAGCCGCTTC 
Jund CGAGCAGCAGCATGCTGAAGA GCCGACCCTGGTTTCAA 
Kir6.2 CTGTCCCGAAAGGGCATTAT CGTTGCAGTTGCCTTTCTTG 
Mafa GAGGAGGTCATCCGACTGAAA GCACTTCTCGCTCTCCAGAAT 
p53 GACCCTGGCACCTACAATGAA GGGTGGATAAATGCAGACAGG 
Pdx1 CTTAACCTAGGCGTCGCACAA GAAGCTCAGGGCTGTTTTTCC 
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Pklr ATCTGGTGATTGTGGTGACAGG GGGGTGTGGGTTGAAAGAAA 
Pregluc TGAGATGAGCACCATTCTGGA TCCGCAGAGATGTTGTGAAGA 
Prkcb CAAGGAGATTCAGCCACCTTAT TTTGTCAGTGGGAGTCAGTTC 
Reg1 GACTCCATGATCCCAAAAGG CACAGTAGCCACGATTGGAA 
Reg2 TCCCCTTGGCTGAAAAAGAC CCAGGTCAAACGGTCTTCAA 
Sirt1 TGGATTTGGAGCTGATGGAG CAATGCTGGTGGAGCAATTC  
Sur1 TCAACTTGTCTGGTGGTCAGC GAGCTGAGAAAGGGTCATCCA 
Ucp2 GGGTTCATGCCTTCCTTTCT AGATTGGTAGGCAGCCATTAGG 
LIVER 
Acc1 TGAGGAGGACCGCATTTATC GCATGGGATGGCAGTAAGGT 
Cyp7a1 AGCAACTAAACAACCTGCCAGTACTA GTCCGGATATTCAAGGATGCA 
F1,6bp CTTGCCATGGATTGTGGTGT TTGATGGCAGGGTCAAAGTC 
Fasn AAGGCTGGGCTCTATGGATT TGAGGCTGGGTTGATACCTC 
Gk1 CTGTTAGCAGGATGGCAGCTT TTTCCTGGAGAGATGCTGTGG 
Hmgcs2 CCGTATGGGCTTCTGTTCAG AGCTTTGTGCGTTCCATCAG 
Mccc1 GGAAAATCGGGTATCCTGTTATG AGACTTCTTCGCCTCCCTCC 
Ppar  CCGTGATGGAAGACCACTCG CAGGTCATATTTGTAATCAGCAACC 
Srebp1a GGAACAGACACTGGCCGAGA GCATAGGGGGCGTCA 
Srebp2 GCGTTCTGGAGACCATGGA ACAAAGTTGCTCTGAAAACAAATCA 
 
 
 
 
 
 
 
 
117 
 
APPENDIX 3 
TABLE D.       Reg2 mutagenesis primers 
 
 M1: G142A ctgccaaccgtgCttattgtgtatcgctgacttc 
M1: G142A atacacaataaGcacggttggcagtgcttggagc 
M1: K157A, D158A aaaaatggGCTgCcgaaaactgtgaggcacag 
M1: K157A, D158A cagttttcgGcAGCccattttttgtatgctgtgtttgtttgaag 
  M2: E59G, D60G, E66G atctaattgGagGAcgtttgacctggggTgGTgctgatctcttttgccagaac 
M2: E59G, D60G, E66G gagatcagcACcAccccaggtcaaacgTCctCcaattagataataacagtaggaacc 
M2: D158G, E159G, E162G aatggaaggGTgGaaactgtgGggcacagtactcctttgtc 
M2: D158G, E159G, E162G tactgtgccCcacagtttCcACccttccattttttgtatgctgtg 
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APPENDIX 4 
Supplemental FIGURE 1 
 
 
Effects of dietary Se concentration [deficiency as (-) and adequacy as (+)] on (A)  body insulin tolerance 
(ITT, 0.5 U/kg) and (B) glucose tolerance (GTT, 1 g/kg). Data were expressed as relative percentages of 
the respective initial (0 min) values, and are presented as means ± SE (n = 4-5). Values at a given time-
point not sharing a common letter differ (P  0.05). 
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APPENDIX 5 
Supplemental FIGURE 2 
 
 
 
 
Effects of dietary Se concentration [deficiency as (-) and adequacy as (+)] on pancreatic islet mRNA 
abundances of insulin-related genes in WT and OE mice at the end of experiment (5 months of age). Data 
were presented as mean ± SE (n = 5).  
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